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ABSTRACT 
Medication adherence is of great public health importance as medication non-adherence 
greatly affects chronic disease burden and total healthcare spending.   This prospective research 
study hypothesizes the relationship between occupational factors and health behaviors by 
examining the theoretical link between medication adherence and job strain as characterized by 
an individual’s physical and psychological stressors.  Such physical and psychological stressors 
can impact a worker’s confidence in his/her ability to exert control over his/her own motivation, 
behavior, and social environment (viz., self-efficacy) – factors that ultimately impact medication 
adherence.  The study examines the association between job type and medication adherence in a 
population of individuals with diabetes and cardiovascular disease (CVD).  Participants with a 
new or existing prescription for oral medications to treat diabetes or hyperlipidemia were 
enrolled into a randomized controlled trial at 34 national chain drugstores in Tennessee.  
Participants received standard care or a Screening and Brief Intervention (SBI) and a pillbox at 
the initial prescription fill, and at each additional refill, provided by a pharmacist.  Medication 
adherence, health care utilization, psychosocial assessment, chronic disease status, and 
occupational health history data were obtained from the participants.  Participants were then 
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stratified by job class and job strain.  Job class was classically defined, while the Karasek 
demand-control model was used to characterize job strain.  The Karasek model describes two 
components of working life that influence job strain.  The first is the psychological demands of 
the job and the second is a worker’s ability to use skills or authority to address those demands.  
Understanding this relationship can provide insight into the development of workplace disease 
prevention and wellness programs that target employees who are at increased risk for poor 
medication adherence as well as provide new insight to healthcare providers on the risk factors 
for poor adherence.  Additionally, developing occupation-specific interventions to improve 
medication adherence may ultimately lead to a reduction in total healthcare spending. 
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1.0  INTRODUCTION 
1.1 CHRONIC DISEASE 
Chronic diseases such as cardiovascular disease (CVD) and diabetes are among the 
leading causes of death and disability in the United States, greatly affecting quality of life and 
healthcare costs (Bodenheimer, Chen, & Bennett, 2009; Kotecha et al., 2013; Schram, Baan, & 
Pouwer, 2009).  Additionally, chronic disease was once thought to be a public health problem 
associated mainly with older age groups, however there has been a shift towards onset in the 
working-age population.  This shift to a younger age group creates an economic burden resulting 
from illness-related loss of productivity due to absence from work (absenteeism) and reduced 
performance while at work (presenteeism) (Mattke et al., 2013).  As a result, workplace wellness 
programs have increased in popularity via the Patient Protection and Affordable Care Act by 
providing health promotion and disease management programs to reduce healthcare spending 
(Mattke, Schnyer, & Van Busum, 2012).  One important component of disease management is 
medication adherence – an individual’s ability to comply with his or her prescribed medication 
regimen (Osterberg & Blaschke, 2005).  Given the emerging relationship between chronic 
disease, work performance, and medication adherence, this dissertation will examine job class 
and job strain and their effect on medication adherence.  Examining occupational factors may 
prove beneficial in developing workplace interventions that improve medication adherence, 
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leading to a reduction in total healthcare spending and a longer living, healthier population 
(Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011).  
1.1.1 Resultant Healthcare Costs of Chronic Disease 
As of 2012, approximately half (117 million) of US adults had one or more chronic 
diseases (Ward, Schiller, & Goodman, 2014).  Additionally, a study by the Milken Institute 
calculated that seven chronic conditions (cancer, heart disease, hypertension, mental disorders, 
diabetes, pulmonary conditions, and stroke) are costing the US economy $1 trillion per year.  
Anticipated growth rates for the aforementioned conditions are expected to yield an illness 
burden of $4 trillion per year by 2023 (DeVol et al., 2007).  The American Heart Association 
estimated total costs of heart disease and stroke in 2010 to be $315.4 billion (Go et al., 2014), 
while the total estimated cost of diagnosed diabetes in 2012 was $245 billion, including $176 
billion in direct medical costs and $69 billion in decreased productivity (e.g. absenteeism, 
presenteeism) (American Diabetes Association, 2013).  As chronic disease prevalence continues 
to increase, it is important to note that these diseases are often preventable and can be managed 
via early detection, improved diet, exercise, and disease management strategies such as 
medication adherence. 
1.2 WORKPLACE WELLNESS 
Employers have invested in workplace wellness programs to combat the chronic disease 
epidemic, causing workplace wellness to have increased to a $6 billion dollar industry in the 
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United States.  In 2012, half of all employers with at least 50 employees offered workplace 
wellness programs, and nearly half of employers without a program indicated that they intended 
to introduce one (Mattke et al., 2013).  Additionally, more than 60% of Americans obtain health 
insurance coverage through an employment-based plan, allowing them access to a workplace 
wellness program (Baicker, Cutler, & Song, 2010).  Workplace wellness programs typically have 
two components: a lifestyle management program and a disease management program.  The 
lifestyle management component focuses on employees with health risks, such as smoking and 
obesity, and providing support in reducing those risks to prevent the development of chronic 
disease.  The disease management component is designed to help employees with a chronic 
disease to take better care of themselves via support mechanisms, such as reminding the 
employee to take their prescribed medications or communicating gaps in care such as missed 
laboratory tests, to their physicians (Mattke et al., 2013). 
Applying improvement strategies to the disease management component of workplace 
wellness programs can result in a return on investment (ROI).  The Rand Corporation found that 
both lifestyle and disease management programs reduced the employer’s average health care 
costs by about $30 per member per month (PMPM) (Caloyeras, Liu, Exum, Broderick, & 
Mattke, 2014; Mattke et al., 2013).  However, the disease management program alone was 
responsible for 87% of those savings.  Employees participating in the disease management 
program generated a savings of $136 PMPM, largely due to a 30% reduction in hospital 
admissions.  While a smaller percentage of employees may participate in a disease management 
program, the ROI is far greater than those employees that participate in a lifestyle management 
program.  Strategizing approaches to improve medication adherence within the workforce can 
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provide a successful way to reach individuals that are not adherent and further improve the 
effectiveness of disease management (Carls et al., 2012; Loeppke et al., 2011). 
1.3 MEDICATION ADHERENCE 
Medication adherence, the compliance with a medication regimen, is generally defined as 
the extent to which individuals take medications as prescribed by their health care providers.  
Improving medication adherence is critical as medication non-adherence is a major problem in 
the management of chronic diseases.  Approximately, 20% – 50%  of individuals do not take 
their medications as prescribed (Kripalani, Yao, & Haynes, 2007) and inadequate adherence has 
been estimated to contribute to $290 billion in unnecessary healthcare costs (Network for 
Excellence in Health Innovation, 2011).  Furthermore, there is no single intervention strategy 
shown to be effective across all individuals, conditions, and settings (World Health Organization, 
2010).  Therefore, strategies that improve medication adherence should be tailored to each 
individual as medication adherence ultimately reduces total annual health care spending 
(Dimatteo, Giordani, Lepper, & Croghan, 2002; Goetzel et al., 2004; Iuga & McGuire, 2014; 
Roebuck et al., 2011; Sokol, McGuigan, Verbrugge, & Epstein, 2005). 
1.4 DISSERTATION OBJECTIVES 
This study hypothesizes for the first time the relationship between occupational factors 
and health behaviors by examining the theoretical link between job type and medication 
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adherence as characterized by an individual’s job strain and physical and psychological stressors.  
Such physical and psychological stressors can impact confidence in the ability to exert control 
over one's own motivation, behavior, and social environment (viz., self-efficacy) – factors that 
ultimately determine medication adherence (Kobau & DiIorio, 2003; Luszczynska, Sarkar, & 
Knoll, 2007).   
Chapter 1 introduces the relationship between chronic diseases, healthcare costs, 
workplace wellness, and medication adherence.  
Chapter 2 describes the hypothesized theoretical model, examining the influence of 
occupational factors (e.g. job class and job strain), physical and psychological stress, and self-
efficacy on the relationship between job type and medication adherence. 
Chapter 3 reviews the rigorous methodology involved with this prospective research 
study.  The study design is presented, along with the occupational questionnaire, characterization 
of occupational factors (e.g. job class and job strain), the intervention (Screening and Brief 
Intervention (SBI) + pillbox) utilized to improve medication adherence, and the measurement, 
proportion days covered (PDC), used to evaluate medication adherence.  Lastly, the statistical 
methods are presented and encompass data collection, covariates used in each model, and the 
modeling method, Generalized Linear Mixed Models (GLMM).   
In Chapter 4, the results are presented as pre-intervention models (i.e. baseline results) 
and intervention moderator models (i.e. models that characterize the intervention’s effect on 
medication adherence) using GLMM.  GLMM, controlling for demographics, marital status, 
education, employment status, income, and baseline measures of health were used to conclude 
that occupational factors such as job strain moderate medication adherence.   
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Chapter 5 provides a discussion of the pre-intervention and the intervention moderator 
model results.   
Lastly, Chapter 6 summarizes the overall scientific contribution of this research study to 
the field of public health with proposed actions for further research. 
By examining the effects of occupational history on medication adherence in a population 
of individuals with diabetes and CVD, a theoretical link between job type and medication 
adherence might be associated with occupational factors (e.g. job class and job strain).  
Understanding this relationship can provide insight into the development of workplace disease 
prevention and wellness programs that target employees who are at increased risk for poor 
medication adherence.  Thus, leading to slower disease progression, reduced mortality, and 
decreased healthcare costs. 
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2.0  THEORETICAL MODEL 
This study hypothesizes the relationship between job type and medication adherence by 
examining occupational factors (e.g. job class and job strain) associated with medication 






Figure 1. Theoretical Model 
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Job class and job strain are used to characterize job type.  Job class is classically defined 
as manual (blue-collar), nonmanual (white-collar), or not working (retired, disabled, and 
unemployed).  Job strain is characterized by Karasek’s demand-control model, where strain is 
defined as either active (high psychological demand, high decision latitude), high strain (high 
psychological demand, low decision latitude), low strain (low psychological demand, high 
decision latitude), passive (low psychological demand, low decision latitude), or non-
contributing (unemployed, disabled, and retired).  In Figure 1, both job class and job strain serve 
as mediator variables in the relationship between job type and medication adherence (Baron & 
Kenny, 1986).  Job class and job strain are considered mediating variables as they are 
determinants that explain why a particular effect occurs between two variables (e.g. job type and 
medication adherence).  Both strain and class can explain how external factors such as job stress 
influence psychological associations such as adherence to a prescribed medication regimen 
(Baron & Kenny, 1986; Diestel & Schmidt, 2009).  Psychological factors including job 
autonomy, self-efficacy, an individual's belief in his or her capacity to execute behaviors 
necessary to produce specific performance attainments, and learned helplessness, when an 
individual lacks the requisite controlling response in a situation but believes this response is 
available to others, can affect an individual’s performance in achieving a desired health outcome 
(Bandura, 1977, 1986, 1997; Strecher, DeVellis, Becker, & Rosenstock, 1986).   
The Theoretical Model can be further expounded to the hypothesized Pre-Intervention 
Theoretical Model depicted in Figure 2.  Physical/psychological stress and self-efficacy are 
additional determinants that should be considered in the relationship between job type and 
medication adherence.  It is hypothesized that stress may have a direct mediational effect on 
adherence, which does not operate through self-efficacy as illustrated by Figure 2.  As a 
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mediator, physical/psychological stress can directly affect the relationship between job type and 
an individual’s ability to perform a health behavior such as medication adherence (Bijl, Van 
Zessen, Ravelli, De Rijk, & Langendoen, 1998; Diestel & Schmidt, 2009).  As a moderator, 
physical/psychological stress can  influence the strength of the relationship between job type and 
self-efficacy in relation to medication adherence (Baron & Kenny, 1986).  In essence, 
physical/psychological stress can serve as both a mediator, to explain why there is a relationship, 










Figure 2. Pre-Intervention Theoretical Model 
 
Figure 3, Intervention Moderator Theoretical Model applies the intervention (SBI + pill 
box), illustrating the hypothesis examined in this dissertation where occupational factors are 
moderators of the intervention effect on medication adherence.  Job class and job strain are 
considered moderators in this model since their interaction with physical/psychological stress 












Figure 3. Intervention Moderator Theoretical Model 
 
Occupational factors such as job class and job strain, physical and psychological stress, 
and self-efficacy will be further described in the subsequent sections of this chapter.   Each 
determinant plays a specific role in understanding the relationship between job type and 
medication adherence. 
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2.1 JOB STRAIN 
The job strain model first postulated by Robert A. Karasek, Jr. has become a widely 
accepted and applied model (Belkic, Landsbergis, Schnall, & Baker, 2004; De Lange, Taris, 
Kompier, Houtman, & Bongers, 2003; Goldberg, Gueguen, Schmaus, Nakache, & Goldberg, 
2001; Häusser, Mojzisch, Niesel, & Schulz-Hardt, 2010; Hellerstedt & Jeffery, 1997; Houtman 
et al., 1999; R. A. Karasek et al., 1988; Kivimäki et al., 2012; Lerner, Levine, Malspeis, & 
D'Agostino, 1994; Pelfrene et al., 2001; Schnall, Landsbergis, & Baker, 1994; Törnroos et al., 
2015).  The job strain model, often referred to as the demand-control model, proposes that job 
strain is not attributed to a single aspect of the work environment, but from the joint effects of 
the demands of a work situation and the range of decision-making freedom or discretion 
available to the worker facing those demands (i.e. job autonomy) (Karasek Jr, 1979).  These two 
aspects of an occupation represent, respectively, action (work load demands, conflicts or other 
stressors which place the individual in a motivated or energized state of "stress") and the 
constraints on the alternative resulting actions (Karasek Jr, 1979). The individual's job decision 
latitude is the constraint which modulates the release or transformation of "stress" potential 
energy into the energy of action (Karasek Jr, 1979). 
While Karasek’s job strain model has been applied to a number of studies, the model is 
often attributed to CVD research and demonstrates that job strain has an impact on 
cardiovascular health (Collins, Karasek, & Costas, 2005; Hellerstedt & Jeffery, 1997; R. 
Karasek, Baker, Marxer, Ahlbom, & Theorell, 1981; R. Karasek, Collins, Clays, Bortkiewicz, & 
Ferrario, 2010; Landsbergis, Schnall, Schwartz, Warren, & Pickering, 1995; Schnall et al., 1994; 
Schnall et al., 1990; Steenland et al., 2000; Theorell & Karasek, 1996).  High strain (high 
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psychological demand, low decision latitude) job types have been found to be negatively 
associated with health, while active (high psychological demand, high decision latitude) and low 
strain (low psychological demand, high decision latitude) job types are positively associated with 
health (Lerner et al., 1994).  Passive (low psychological demand, low decision latitude) job types 
fall within the spectrum.   Not only does the addition of job strain to the hypothesized models 
allow the use of a widely accepted tool for characterizing job type, but the job strain model is 
also appropriate as the prospective research study presented in this dissertation examines a 
population of individuals with CVD and diabetes.   
Job strain acts as a mediator in the Pre-Intervention Theoretical Model accounting for the 
relation between job type and medication adherence.  Job strain characterizes job type in terms of 
physical/psychological factors which can impact an individual outside of the workplace.  As a 
mediating variable, job strain explains how external factors such as job stress can cause a 
particular effect to occur (i.e. adherence to a prescribed medication regimen) (Baron & Kenny, 
1986; Diestel & Schmidt, 2009).  In the Intervention Moderator Theoretical Model, job strain 
becomes a moderator of the relationship between job type and medication adherence, affecting 
the magnitude of the intervention’s effect on medication adherence.  Ultimately, job strain is 
hypothesized to be a key determinant in the relationship between job type and medication 
adherence.   
2.2 PHYSICAL AND PSYCHOLOGICAL STRESS 
 The National Institute for Occupational Safety and Health (NIOSH) states that job stress 
can be defined as the harmful physical and emotional responses that occur when the 
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requirements of the job do not match the capabilities, resources, or needs of the worker (Sauter et 
al.).  Exposure to stressful working conditions or job stressors can directly affect a worker’s 
safety and health.  These factors are presented in both the Pre-Intervention Theoretical Model 
and Intervention Moderator Theoretical Model.   
Physical and psychological stressors have been shown to evoke biological responses that 
cause a predisposition to disease or poor health outcomes by a variety of mechanisms via the 
nervous, cardiovascular, endocrine, and immune systems (Schneiderman, Ironson, & Siegel, 
2005).  Studies have shown both acute and chronic biological responses to stress.  For example, 
increased cortisol levels (Schulz, Kirschbaum, Prüßner, & Hellhammer, 1998), activation of 
cellular responses by the immune system (Dhabhar & Mcewen, 1997), and cardiovascular 
responses such as increased blood pressure (Vrijkotte, Van Doornen, & De Geus, 2000).  
Psychosocial stressors have also been extensively studied and linked to disease.  For example, 
psychosocial stressors, such as job strain, anxiety, and stress have been linked to CVD (Houtman 
et al., 1999; R. Karasek et al., 1981; R. A. Karasek et al., 1988; Kivimäki et al., 2012; Rozanski, 
Blumenthal, & Kaplan, 1999). 
Physical/psychological stress serves as a mediator in the relationship between job type 
and medication adherence in that physical and psychological stressors can have a direct impact 
on an individual’s ability to adhere to their prescribed medication regimen.  Self-efficacy, an 
individual’s confidence in his/her ability to exert control over his/her own motivation, behavior, 
and social environment, affects an individual’s self-regulation of disease prevention and 
management (Clark & Dodge, 1999).  Physical/psychological stress can act as a moderator of 
self-efficacy in the relationship between job type and medication adherence in that it moderates 
an individual’s ability to perform a health behavior such as compliance to their prescribed 
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medication regimen (Grau, Salanova, & Peiro, 2001).  Additionally, physical/psychological 
stress are impacted by job strain and can affect an individual’s ability to perform a desired health 
behavior (Jex & Bliese, 1999; Jex & Gudanowski, 1992). 
It is also important to note that a reciprocal relationship exists between physical and 
psychological stress.  For example, physical stressors may cause a proclivity to psychological 
stressors (e.g. lack of autonomy may cause disengagement by an employee yielding anxiety) and 
psychological stressors may manifest as physical stressors (e.g. anxiety due to work overload can 
result in exhaustion) (Cohen, Janicki-Deverts, & Miller, 2007; Cohen, Kessler, & Gordon, 1995).  
Physical/psychological stress is hypothesized as a key determinant in both the pre-intervention 
and intervention moderator theoretical models as it can play a role, respectively or mutually, in 
the relationship between job type and health behaviors (i.e. medication adherence) (Blair, Jacobs 
Jr, & Powell, 1985; Cooper & Cartwright, 1994; DeLongis, Folkman, & Lazarus, 1988; Ng & 
Jeffery, 2003).     
2.3 SELF-EFFICACY  
Self-efficacy refers to an individual's belief in his or her capacity to execute behaviors 
necessary to produce specific performance attainments (Bandura, 1977, 1986, 1997).  Often 
analyzed as a determinant of health behavior change (AbuSABHA & Achterberg, 1997; 
Bandura, 1990; DiClemente, Fairhurst, & Piotrowski, 1995; Kelly, Zyzanski, & Alemagno, 
1991; O'Leary, 1985; Strecher et al., 1986), self-efficacy is the result of the interaction of 
personal, behavioral and environmental factors (Clark & Dodge, 1999).   
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In Figures 2 and 3, Pre-Intervention Theoretical Model and Intervention Moderator 
Theoretical Model, respectively, it is hypothesized that self-efficacy mediates the relationship 
between job type and medication adherence (Brown & Bussell, 2011; Judge & Bono, 2001; 
Schaubroeck & Merritt, 1997).  Additionally, self-efficacy has become a key construct in 
developing interventions to improve chronic disease outcomes (e.g. interventions that improve 
medication adherence) (Herrick, Stone, & Mettler, 1997; Marks & Allegrante, 2005).    
Therefore, self-efficacy is hypothesized as a key determinant in the relationship between job type 
and medication adherence, in that it can affect physical/psychological stress.     
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3.0  METHODS 
3.1 STUDY DESIGN 
The participants in this study were participants of the randomized controlled trial (RCT), 
Effect of Community Pharmacist Intervention on adherence to Long-term medications, (ECO-
PHIL) study.  Individuals with a new or existing prescription for oral medications and a 
diagnosis of diabetes or hyperlipidemia were enrolled into the trial at one of 34 drugstores of a 
national pharmacy chain in Tennessee.   
Participants were randomized via permuted block design into one of two groups; standard 
care treatment group and intervention treatment group.  The standard care treatment group 
received care as usual by the pharmacist.  The intervention treatment group (SBI + pillbox) 
received both a Screening and Brief Intervention (SBI) and a pillbox based upon motivational 
interviewing principles at the initial prescription fill, and at each additional refill.  Additional 
inclusion criteria required that participants be 30 – 85 years of age, comfortable speaking 
English, not institutionalized, and not diagnosed with psychosis or dementia.  Medication 
adherence, occupational health history, health care utilization, psychosocial assessment, and 
chronic disease status data from participants were obtained.  Medication adherence data were 
drawn from pharmacy claims data, covering a period of one year before each participant’s 
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enrollment date into the study and at the conclusion of their involvement with the study.  
Occupational health history was collected through a self-report questionnaire (Appendix A). 
Participants were then stratified by job class and job strain.  Lastly, GLMM, controlling 
for demographics, marital status, education, employment status, income, and baseline measures 
of health were used to conclude that occupational factors exhibit a moderating effect on 
medication adherence.   
3.2 OCCUPATIONAL HEALTH QUESTIONNAIRE 
Participants (n=506) were administered an occupational health questionnaire (Appendix 
A) devised from the Economic Form 90, an instrument used to assess economic outcomes, and 
tailored to this study population (Bray et al., 2007).  The University of Pittsburgh Institutional 
Review Board provided approval and oversight of this study, IRB# MOD12050040-
03/PRO12050040, Prospective Study on a Pharmacist-led Intervention to Improve Medication 
Adherence (Appendix B).  Participants were asked to report via self-addressed stamped envelope 
or telephonic interview: 1) their job title or most recent job title if they were not currently 
working; 2) their job setting or most recent job setting if they were not currently working; and 3) 
their current income range or prior income range if they were not currently working.  The 
reported job title and job setting were used to characterize each participant’s job type by job class 
and job strain.   
 19 
3.3 CHARACTERIZATION OF OCCUPATIONAL FACTORS 
Participants were stratified by job class and job strain.  Job class was classically defined 
and divided into three categories: manual (blue-collar), nonmanual (white-collar), and not 
working (retired, disabled, and unemployed).  Job strain was characterized by Karasek’s 
demand-control model.  This model describes two dimensions of working life that influence job 
strain: the psychological demands of the job and the worker’s ability to use skills or authority to 
address those demands (i.e. decision latitude) (Hellerstedt & Jeffery, 1997).   
Job strain was divided into five categories.  The first four categories are based on the 
Karasek model: active (high psychological demand, high decision latitude), high strain (high 
psychological demand, low decision latitude), low strain (low psychological demand, high 
decision latitude), and passive (low psychological demand, low decision latitude).  A fifth 
category was created and termed ‘non-contributing’, containing a combination of unemployed, 
disabled, and retired participants.  The participant’s job type was matched to the appropriate job 
strain using the Occupational Distribution of Psychosocial Job Characteristics (Appendix C) 
created from the US Department of Labor Quality of Employment Surveys (QES) of the full 
work force in 1969, 1972, and 1977 (R. A. Karasek et al., 1988).  
3.4 THE INTERVENTION 
Participants randomized into the intervention group (SBI + pillbox) received both a 
pillbox and a Screening and Brief Intervention (SBI) based upon motivational interviewing 
principles at the initial prescription fill, and at each subsequent refill.  The pillbox served as a 
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passive reminder for the participant to adhere to their medication regimen.  The SBI served as 
the active approach.   
The SBI is a brief 2 – 5 minute conversation led by the pharmacist using motivational 
interviewing (MI) principles to address specific issues that may affect an individual’s initial and 
continued use of their prescribed medication regimen.  MI employs the use of open-ended 
questions, appropriate affirmations, and reflective listening, as an individual is guided through a 
process where they can explore and understand the barriers to changing their behavior and 
identify strategies to help them overcome those barriers (Miller & Rollnick, 2002).  MI has been 
used to address a number of other health behaviors including tobacco cessation, diet and 
exercise, diabetes self-management, oral health (Martins & McNeil, 2009), mental health 
(Rollnick, Miller, & Butler, 2008), sexual health (Petersen, Albright, Garrett, & Curtis, 2007), 
and chronic pain (Rau, Ehlebracht-König, & Petermann, 2008).   
The RCT utilized a paradigm developed by the study’s Principal Investigator called 
POLAR*S™.  POLAR*S is an acronym for the following application of motivational 
interviewing: Permission (P), Open-ended questions (O), Reflective Listening (L), Affirmation 
(A), Roll with Resistance (R), and Summary (S).  Pharmacists were trained in the use of the 
adherence-focused brief intervention designed for a typical community pharmacy setting.  The 
paradigm has been reported to be helpful in both initiating and completing an SBI with any given 
individual (Pringle, Boyer, Conklin, McCullough, & Aldridge, 2014). 
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3.5 MEASUREMENT OF ADHERENCE: PDC 
Medication adherence was measured as proportion of days covered (PDC) using the 
Pharmacy Quality Alliance’s (PQA) convention which includes a set of National Drug Codes 
(NDCs) for five classes of chronic disease medications: beta blockers (BB), calcium channel 
blockers (CCB), diabetes, renin angiotensin system antagonists (RASA), and statins.  PDC is 
calculated as the total number of days an individual is supplied a medication during an interval 
divided by the total number of days during that interval (Iuga & McGuire, 2014).   Most 
participants enrolled in the study were taking more than one of the specified medication classes.  
Therefore, in addition to each individual class, variables were constructed based on these five 
classes to measure different aspects of a participant’s overall behavior (e.g. their average 
adherence across all relevant classes).  Adherence measures were constructed from pharmacy 
claims data provided by the national drugstore chain.  PDC and PDC80, a benchmark 
measurement for >80% of days covered, were estimated as continuous variables.  For example, 
binary PDC80 outcomes were estimated as a linear probability model. 
3.6 STATISTICAL ANALYSIS 
3.6.1 Data Collection 
Participant enrollment began July 2, 2012 and concluded on April 27, 2013. Upon 
enrollment, participants were asked to complete a baseline interview conducted by research 
personnel for the collection of chronic disease status, health care utilization, and psychosocial 
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assessment data.  Follow-up interviews were also conducted at six and nine month intervals, 
respectively, for the collection of occupational health data in addition to baseline information.  
Medication adherence data via administrative claims data was obtained for a time period of one 
year prior to the participant’s enrollment date in the RCT through the final nine month follow-up 
interview.     
Performance metrics were developed for various study activities including the completion 
of participant interviews, ascertainment of medical records, and entry of the data collected.    To 
ensure fidelity of the SBIs for those participants randomized into the intervention treatment 
group, pharmacists completed standard forms to document their SBI with participants each time 
they presented at the pharmacy for a prescription refill.  This documentation was then sent to the 
research team and added to the study file for each participant.  Weekly quality improvement 
meetings were held among research staff to address any obstacles in reaching the established 
data metrics.  Participant enrollment forms and study questionnaires were checked for 
completeness and accuracy.   Discrepant or missing data were resolved using several techniques, 
including the review of other study documents that contained similar information, 
communicating with the pharmacy that enrolled the participant, or communicating with the 
participant directly.   
A data review was conducted monthly by research personnel on a 10% random sample of 
the data collected.  The established quality metric of 98% data accuracy (a comparison of data 
being entered into the Structured Query Language (SQL) database against the original data 
source) was reached continually for each data domain.  If data were found to be discrepant 
against the data source, verified data changes were entered into the SQL database with 
appropriate documentation.  Systemic issues (such as conventions for determining dates) that 
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may have resulted in data entry errors were addressed in the weekly quality improvement 
meetings and process changes were made to resolve these errors. 
3.6.2 Covariates 
To examine the associations with medication adherence, analyses controlled for 
demographics, marital status, education status, employment status, income, and baseline 
measures of health.  Baseline measures of health included diabetes diagnosis, cholesterol 
diagnosis, heart disease diagnosis, hypertension diagnosis, stroke diagnosis, depression 
diagnosis, and an indicator for any other chronic disease diagnosis.  Employment status was 
characterized as full-time, part-time, retired, disabled, and unemployed.  Current and prior 
income was classified by the following ranges and treated as a continuous variable: $0 – 
$15,000, $15,001 – $30,000, $30,001 – $50,000, $50,001 – $75,000, $75,001 – $100,000, and 
more than $100,000.  Covariates were used in one of two models.  The first model or pre-
intervention model analyzes PDC at baseline for job class and job strain.  The second model or 
intervention moderator model estimates how job class and job strain influence the intervention’s 
effect on PDC.  Table 1 summarizes the covariates used in the pre-intervention models, while 
Table 2 presents the covariates used in the intervention moderator models.  Pairwise t-tests are 
included for key variables by job class and job strain in Appendix D.  
Table 1. Pre-Intervention Model Variables 
Variable Description 
disease 
Proportion of individuals with Diabetes, indicator variable (0 if 
not present, 1 if present)  
pdc Proportion Days Covered (PDC), continuous variable 
pdcmbb0 
Proportion Days Covered (PDC) for beta blockers (BB) 
medication class pre-intervention, continuous variable 
pdcmccb0 
Proportion Days Covered (PDC) for calcium channel blockers 
(CCB) medication class pre-intervention, continuous variable 
pdcmdiab0 Proportion Days Covered (PDC) for diabetes medication class 
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Variable Description 
pre-intervention, continuous variable 
pdcmrasa0 
Proportion Days Covered (PDC) for renin angiotensin system 
antagonists (RASA) medication class pre-intervention, 
continuous variable 
pdcmstat0 
Proportion Days Covered (PDC) for statins medication class, 
pre-intervention, continuous variable 
pdc80bb0 
Proportion Days Covered >80% (PDC80) for beta blockers 
(BB) medication class pre-intervention, indicator variable (0 if 
not present, 1 if present) 
pdc80ccb0 
Proportion Days Covered >80% (PDC80) for calcium channel 
blockers (CCB) medication class pre-intervention, indicator 
variable (0 if not present, 1 if present) 
pdc80diab0 
Proportion Days Covered >80% (PDC80) for diabetes 
medication class pre-intervention, indicator variable (0 if not 
present, 1 if present) 
pdc80raas0 
Proportion Days Covered >80% (PDC80) for renin angiotensin 
system antagonists (RASA) medication class pre-intervention, 
indicator variable (0 if not present, 1 if present) 
pdc80stat0 
Proportion Days Covered >80% (PDC80) for statins 
medication class pre-intervention, indicator variable (0 if not 
present, 1 if present) 
mdage Age, continuous variable 
mdf Female, indicator variable (0 if not present, 1 if present) 
mdnonwh Non-white, indicator variable (0 if not present, 1 if present) 
mdedm1 
Individual has less than a high school degree, indicator 
variable (0 if not present, 1 if present) 
mdedm2 
Individual has a high school degree, indicator variable (0 if not 
present, 1 if present) 
mdedm3 
Individual has a four-year degree, indicator variable (0 if not 
present, 1 if present) 
mdedm4 
Individual has a professional/graduate level degree, indicator 
variable (0 if not present, 1 if present) 
mdmarpar 
Individual is married/partnered, indicator variable (0 if not 
present, 1 if present) 
mdlivhom 
Independent living, indicator variable (0 if not present, 1 if 
present) 
mdemp1 
Employed full-time, indicator variable (0 if not present, 1 if 
present) 
mdemp2 
Employed part-time, indicator variable (0 if not present, 1 if 
present) 
mdemp3 Retired, indicator variable (0 if not present, 1 if present) 
mdemp4 Disabled, indicator variable (0 if not present, 1 if present) 
mdemp5 Not employed, indicator variable (0 if not present, 1 if present) 
incc1 Current income between $0 - $15,000, continuous variable 
incc2 
Current income between $15,001 - $30,000, continuous 
variable 
incc3 
Current income between $30,001 - $50,000, continuous 
variable 
incc4 Current income between $50,001-$75,000, continuous variable 
incc5 
Current income between $75,001-$100,000, continuous 
variable 
incc6 Current income is more than $100,000, continuous variable 
incp1 Prior income is between $0 - $15,000, continuous variable 
incp2 
Prior income is between $15,001 - $30,000, continuous 
variable 
incp3 
Prior income is between $30,001 - $50,000, continuous 
variable 
incp4 






Prior income is between $75,001 - $100,000, continuous 
variable 
incp6 Prior income is more than $100,000, continuous variable 
mdbins1 
Insured via individual plan, indicator variable (0 if not present, 
1 if present) 
mdbins2 
Insured via group plan, indicator variable (0 if not present, 1 if 
present) 
mdbins3 
Insured via military/government, indicator variable (0 if not 
present, 1 if present) 
mdbins4 
Insured via Medicaid, indicator variable (0 if not present, 1 if 
present) 
mdbins5 
Insured via Medicare, indicator variable (0 if not present, 1 if 
present) 
mdbins6 Not insured, indicator variable (0 if not present, 1 if present) 
mddxdiab 
Diabetes diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxchol 
Cholesterol diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxhrtd 
Heart disease diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxbp 
Hypertension diagnosis, indicator variable (0 if not present, 1 
if present) 
mddxstrk 
Stroke diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxdepr 
Depression diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxothe 
Other chronic disease diagnosis, indicator variable (0 if not 
present, 1 if present) 
mddrqs1 
When you visit your doctor, how often do you prepare a list of 
questions for your doctor?, continuous variable (1 = never to 6 
= always) 
mddrqs2 
When you visit your doctor, how often do you ask questions 
about the things you don’t understand about your treatment?, 
continuous variable (1 = never to 6 = always) 
mddrqs3 
When you visit your doctor, how often do you discuss any 
personal problems that may be related to your illness?, 
continuous variable (1 = never to 6 = always) 
mdhealth 
In general, you would say your health is?, continuous variable 
(1 = excellent to 5 = poor) 
Table 2. Intervention Moderator Model Variables 
Variable Description 
disease 
Proportion of individuals with Diabetes, indicator variable (0 if 
not present, 1 if present)  
pdc Proportion Days Covered (PDC), continuous variable 
pdcmbb0 
Proportion Days Covered (PDC) for beta blockers (BB) 
medication class pre-intervention, continuous variable 
pdcmbb1 
Proportion Days Covered (PDC) for beta blockers (BB) 
medication class post-intervention, continuous variable 
pdcmccb0 
Proportion Days Covered (PDC) for calcium channel blockers 
(CCB) medication class pre-intervention, continuous variable 
pdcmccb1 
Proportion Days Covered (PDC) for calcium channel blockers 
(CCB) medication class post-intervention, continuous variable 
pdcmdiab0 
Proportion Days Covered (PDC) for diabetes medication class 
pre-intervention, continuous variable 




post-intervention, continuous variable 
pdcmrasa0 
Proportion Days Covered (PDC) for renin angiotensin system 
antagonists (RASA) medication class pre-intervention, 
continuous variable 
pdcmraas1 
Proportion Days Covered (PDC) for renin angiotensin system 
antagonists (RASA) medication class post-intervention, 
continuous variable 
pdcmstat0 
Proportion Days Covered (PDC) for statins medication class, 
pre-intervention, continuous variable 
pdcmstat1 
Proportion Days Covered (PDC) for statins medication class, 
post-intervention, continuous variable 
pdc80bb0 
Proportion Days Covered >80% (PDC80) for beta blockers 
(BB) medication class pre-intervention, indicator variable (0 if 
not present, 1 if present) 
pdc80bb1 
Proportion Days Covered >80% (PDC80) for beta blockers 
(BB) medication class post-intervention, indicator variable (0 
if not present, 1 if present) 
pdc80ccb0 
Proportion Days Covered >80% (PDC80) for calcium channel 
blockers (CCB) medication class pre-intervention, indicator 
variable (0 if not present, 1 if present) 
pdc80ccb1 
Proportion Days Covered >80% (PDC80) for calcium channel 
blockers (CCB) medication class post-intervention, indicator 
variable (0 if not present, 1 if present) 
pdc80diab0 
Proportion Days Covered >80% (PDC80) for diabetes 
medication class pre-intervention, indicator variable (0 if not 
present, 1 if present) 
pdc80diab1 
Proportion Days Covered >80% (PDC80) for diabetes 
medication class pre-intervention, indicator variable (0 if not 
present, 1 if present) 
pdc80raas0 
Proportion Days Covered >80% (PDC80) for renin angiotensin 
system antagonists (RASA) medication class pre-intervention, 
indicator variable (0 if not present, 1 if present) 
pdc80raas1 
Proportion Days Covered >80% (PDC80) for renin angiotensin 
system antagonists (RASA) medication class post-intervention, 
indicator variable (0 if not present, 1 if present) 
pdc80stat0 
Proportion Days Covered >80% (PDC80) for statins 
medication class pre-intervention, indicator variable (0 if not 
present, 1 if present) 
pdc80stat1 
Proportion Days Covered >80% (PDC80) for statins 
medication class post-intervention, indicator variable (0 if not 
present, 1 if present) 
mdage Age, continuous variable 
mdf Female, indicator variable (0 if not present, 1 if present) 
mdnonwh Non-white, indicator variable (0 if not present, 1 if present) 
mdedm1 
Individual has less than a high school degree, indicator 
variable (0 if not present, 1 if present) 
mdedm2 
Individual has a high school degree, indicator variable (0 if not 
present, 1 if present) 
mdedm3 
Individual has a four-year degree, indicator variable (0 if not 
present, 1 if present) 
mdedm4 
Individual has a professional/graduate level degree, indicator 
variable (0 if not present, 1 if present) 
mdmarpar 
Individual is married/partnered, indicator variable (0 if not 
present, 1 if present) 
mdlivhom 
Independent living, indicator variable (0 if not present, 1 if 
present) 
mdemp1 
Employed full-time, indicator variable (0 if not present, 1 if 
present) 





mdemp3 Retired, indicator variable (0 if not present, 1 if present) 
mdemp4 Disabled, indicator variable (0 if not present, 1 if present) 
mdemp5 Not employed, indicator variable (0 if not present, 1 if present) 
incc1 Current income between $0 - $15,000, continuous variable 
incc2 
Current income between $15,001 - $30,000, continuous 
variable 
incc3 
Current income between $30,001 - $50,000, continuous 
variable 
incc4 Current income between $50,001-$75,000, continuous variable 
incc5 
Current income between $75,001-$100,000, continuous 
variable 
incc6 Current income is more than $100,000, continuous variable 
incp1 Prior income is between $0 - $15,000, continuous variable 
incp2 
Prior income is between $15,001 - $30,000, continuous 
variable 
incp3 
Prior income is between $30,001 - $50,000, continuous 
variable 
incp4 
Prior income is between $50,001 - $75,000, continuous 
variable 
incp5 
Prior income is between $75,001 - $100,000, continuous 
variable 
incp6 Prior income is more than $100,000, continuous variable 
mdbins1 
Insured via individual plan, indicator variable (0 if not present, 
1 if present) 
mdbins2 
Insured via group plan, indicator variable (0 if not present, 1 if 
present) 
mdbins3 
Insured via military/government, indicator variable (0 if not 
present, 1 if present) 
mdbins4 
Insured via Medicaid, indicator variable (0 if not present, 1 if 
present) 
mdbins5 
Insured via Medicare, indicator variable (0 if not present, 1 if 
present) 
mdbins6 Not insured, indicator variable (0 if not present, 1 if present) 
mddxdiab 
Diabetes diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxchol 
Cholesterol diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxhrtd 
Heart disease diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxbp 
Hypertension diagnosis, indicator variable (0 if not present, 1 
if present) 
mddxstrk 
Stroke diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxdepr 
Depression diagnosis, indicator variable (0 if not present, 1 if 
present) 
mddxothe 
Other chronic disease diagnosis, indicator variable (0 if not 
present, 1 if present) 
mddrqs1 
When you visit your doctor, how often do you prepare a list of 
questions for your doctor?, continuous variable (1 = never to 6 
= always) 
mddrqs2 
When you visit your doctor, how often do you ask questions 
about the things you don’t understand about your treatment?, 
continuous variable (1 = never to 6 = always) 
mddrqs3 
When you visit your doctor, how often do you discuss any 
personal problems that may be related to your illness?, 
continuous variable (1 = never to 6 = always) 
mdhealth 
In general, you would say your health is?, continuous variable 
(1 = excellent to 5 = poor) 
Table 2 continued
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3.6.3 Generalized Linear Mixed Models 
Multivariate statistics were examined using GLMM.  GLMM allow response variables 
from different distributions, such as binary responses and includes both fixed and random 
effects, hence mixed models.  The general linear form of the model, in matrix notation, is shown 
in equation 1: 
y = Xβ + Zγ+ε + ε, 
(1) 
where X is the fixed effects or covariates and Z is the random effects or individuals nested within 
pharmacies. 
Models were created for PDC as a function of job class and job strain, respectively, and 
are presented in the following equations for pre-intervention and intervention moderator models.  
The pre-intervention model depicting PDC at baseline for job class is shown in equation 
2: 
PDCi, m = βo + β1JOB CLASSi + Xiβ2 + εp + εi, 
(2) 
where PDCi, m is the proportion days covered by individual (i) and medication class (m), βo is the 
intercept, β1 is the set of coefficients for each of the job class indicator variables, JOB CLASSi is 
a set of indicator variables classified as manual (blue-collar), nonmanual (white-collar), or not 
working (retired, disabled, and unemployed) by individual (i), Xi represents all other covariates 
in the model at the individual (i) level, β2 is the set of coefficients for the covariates, εp is the 
model prediction error by pharmacy (p) and εi is the model prediction error by individual (i). 
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The pre-intervention model representing PDC at baseline for job strain is shown in 
equation 3: 
PDCi, m = βo + β1JOB STRAINi + Xiβ2 + εp + εi, 
(3) 
where PDCi, m is the proportion days covered by individual (i) and medication class (m), βo is the 
intercept, β1 is the set of coefficients for each of the job strain indicator variables, JOB STRAINi 
is a set of indicator variables classified as active, high strain, low strain, passive, and non-
contributing by individual (i), Xi represents all other covariates in the model at the individual (i) 
level, β2 is the set of coefficients for the covariates, εp is the model prediction error by pharmacy 
(p) and εi is the model prediction error by individual (i). 
The intervention moderator model demonstrating the intervention’s effect on PDC in 
relation to job class is shown in equation 4: 
PDCi = βo + β1 JOB CLASSi + β2INTERVENTION + β3JOB 
CLASS*INTERVENTION + Xiβ4 + εp + εi, 
(4) 
where PDCi is the proportion days covered by individual, βo is the intercept, β1 is a set of 
coefficients for each of the job class indicator variables, JOB CLASSi is an indicator variable 
classified as manual (blue-collar), nonmanual (white-collar), or not working (retired, disabled, 
and unemployed) by individual (i), β2 is the coefficient for the main effect of the intervention, 
INTERVENTION is the effect of SBI + pillbox, β3 is the main coefficient of interest for this 
analysis and represents the moderating effect of job class on the intervention, JOB 
CLASS*INTERVENTION is the interaction term between each of the job class indicators and 
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the intervention indicator, Xi represents all other covariates in the model at the individual (i) 
level, β4 is the set of coefficients for the covariates, εp is the model prediction error by pharmacy 
(p) and εi is the model prediction error by individual (i). 
The intervention moderator model demonstrating the intervention’s effect on PDC in 
relation to job strain is shown in equation 5: 
PDCi = βo + β1 JOB STRAINi + β2INTERVENTION + β3JOB STRAIN*INTERVENTION 
+ Xiβ4 + εp + εi, 
(5) 
where PDCi is the proportion days covered by individual, βo is the intercept, β1 is a set of 
coefficients for each of the job strain indicator variables, JOB STRAINi is an indicator variable 
classified as active, high strain, low strain, passive, and non-contributing by individual (i), β2 is 
the coefficient for the main effect of the intervention, INTERVENTION is the effect of SBI + 
pillbox, β3 is the main coefficient of interest for this analysis and represents the moderating effect 
of job strain on the intervention, JOB STRAIN*INTERVENTION is the interaction term 
between each of the job strain indicators and the intervention indicator, Xi represents all other 
covariates in the model at the individual (i) level, β4 is the set of coefficients for the covariates, εp
is the model prediction error by pharmacy (p) and εi is the model prediction error by individual 
(i). 
GLMM allowed for each outcome to be measured independently even though the study 
involved multiple data sources, data collection methods, and different analysis samples that 
emerged for any given outcome of interest (e.g. the sample of participants with PDC adherence 
measures, though overlapping, was distinct from participants with healthcare utilization data). 
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Covariates across multiple data sets were utilized when available.  The GLMM efficiently 
modeled repeated measures within individual participants and pharmacies for fixed/random 
effects and clustering (McCulloch & Neuhaus, 2005).  Moreover, within the GLMM framework, 
hypotheses were explored on multiple levels.  Pairwise comparisons of job class and job strain 
utilized a reference category.  Post-estimation f-tests were used to compare between job class 
and job strain that were not specified as the reference category.  STATA (version 13, StataCorp, 
College Station, TX) software was used for the analyses. 
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4.0 RESULTS 
4.1 SAMPLE SELECTION 
The occupational health questionnaire was administered to all participants (n=506) with a 
sample of n=210 completing the questionnaire (response rate of 41.5%).  A final sample of 
n=189 was used for the analysis as pharmacy claims data was provided for these participants.  
Figure 4 depicts the sample of participants.  Non-response to the survey did not appear to vary 

















Figure 4. Study Sample 
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4.2 DESCRIPTIVE STATISTICS 
Descriptive statistics of all relevant sample characteristics are tabulated and presented by 
job strain and job class in Table 3.  Continuous covariate outcomes are presented as means and 
standard errors.  Categorical covariates are described as percentages.  Covariates that were found 
to be related to medication adherence are noted within Table 3.  
Approximately, half of all individuals were enrolled in the RCT with a primary diagnosis 
of diabetes.  The average participant age was 61 and roughly half of the study population was 
female.  Sixty-one percent were married or had a partner.  Less than 20% of the sample failed to 
complete high school.  Thirty-one percent were employed full-time and 59% were retired, 
disabled, or not employed.  Most participants had individual insurance plans (84.4%).  
Participants had a baseline PDC of 62.8%.  Lastly, job class and job strain had equivalent 
baseline characteristics across a variety of measures of health and health behaviors.  
Table 3. Sample Characteristics 
Total 
Sample 







Contributing Manual Nonmanual 
Not 
Working 
N 189 64 35 33 42 15 50 120 19 
Standard Care (%) 19% 11% 7.4% 12.2% 4% 14% 35% 5% 
SBI + pillbox (%) 15% 7.4% 10% 10% 4% 13% 28% 5% 
Diabetes Proportion 
0.524 0.531 0.514 0.515 0.548 0.467 0.480 0.558 0.421 
(0.036) (0.063) (0.086) (0.088) (0.078) (0.133) (0.071) (0.046) (0.116) 
PDC 
0.628 0.675 0.611 0.735 0.599 0.581 0.666 0.652 0.578 
(0.035) (0.059) (0.082) (0.077) (0.076) (0.127) (0.067) (0.043) (0.113) 
PDC 
BB 
Pre 0.657 0.667 0.659 0.742 0.566 0.646 0.608 0.686 0.662 
Post (0.038) (0.066) (0.088) (0.057) (0.09) (0.18) (0.061) (0.05) (0.153) 
CCB 
Pre 0.789 0.708 0.859 0.840 0.779 0.897 0.795 0.768 0.897 
Post (0.031) (0.064) (0.052) (0.057) (0.072) (0.084) (0.051) (0.044) (0.071) 
Diabetes 
Pre 0.657 0.656 0.663 0.719 0.682 0.528 0.754 0.643 0.553 















Pre 0.718 0.733 0.573 0.916 0.719 0.701 0.818 0.694 0.652 
Post (0.04) (0.058) (0.109) (0.031) (0.12) (0.121) (0.06) (0.054) (0.127) 
Statins 
Pre 0.696 0.763 0.639 0.713 0.654 0.609 0.626 0.737 0.606 
Post (0.029) (0.042) (0.072) (0.06) (0.076) (0.109) (0.064) (0.034) (0.097) 
PDC80 
BB 
Pre 0.560 0.630 0.533 0.500 0.429 0.800 0.385 0.651 0.667 
Post (0.058) (0.095) (0.133) (0.139) (0.137) (0.2) (0.097) (0.074) (0.211) 
CCB 
Pre 0.727 0.692 0.813 0.714 0.667 0.833 0.704 0.721 0.857 
Post (0.051) (0.092) (0.101) (0.125) (0.126) (0.167) (0.09) (0.069) (0.143) 
Diabetes 
Pre 0.581 0.727 0.313 0.875 0.556 0.429 0.625 0.595 0.444 
Post (0.063) (0.097) (0.12) (0.125) (0.176) (0.202) (0.125) (0.082) (0.176) 
RASA 
Pre 0.672 0.593 0.667 0.900 0.750 0.571 0.750 0.650 0.625 
Post (0.059) (0.096) (0.142) (0.1) (0.164) (0.202) (0.112) (0.076) (0.183) 
Statins 
Pre 0.550 0.615 0.450 0.450 0.652 0.444 0.464 0.597 0.455 
Post (0.047) (0.079) (0.114) (0.114) (0.102) (0.176) (0.096) (0.058) (0.157) 
Age 
61 61 60 60 59 65 60 60 66 
(0.786) (1.319) (1.855) (1.770) (1.782) (2.805) (1.488) (0.989) (2.433) 
Female 
0.543 0.578 0.853 0.273 0.405 0.667 0.280 0.625 0.722 
(0.036) (0.062) (0.062) (0.079) (0.077) (0.126) (0.064) (0.044) (0.109) 
Non-white 
0.128 0.143 0.143 0.152 0.048 0.200 0.080 0.143 0.158 
(0.024) (0.044) (0.060) (0.063) (0.033) (0.107) (0.039) (0.032) (0.086) 
Less than High 
School Degree
0.176 0.048 0.314 0.061 0.214 0.533 0.300 0.076 0.474 
(0.028) (0.027) (0.080) (0.042) (0.064) (0.133) (0.065) (0.024) (0.118) 
High School Degree 
0.277 0.143 0.286 0.364 0.429 0.200 0.500 0.185 0.263 
(0.033) (0.044) (0.077) (0.085) (0.077) (0.107) (0.071) (0.036) (0.104) 
Four-year Degree 
0.282 0.254 0.314 0.333 0.262 0.267 0.120 0.353 0.263 
(0.033) (0.055) (0.080) (0.083) (0.069) (0.118) (0.046) (0.044) (0.104) 
Professional/Graduate 
Level Degree 
0.266 0.556 0.086 0.242 0.095 0.000 0.080 0.387 0.000 
(0.032) (0.063) (0.048) (0.076) (0.046) (0.000) (0.039) (0.045) (0.000) 
Married/Partnered 
0.612 0.730 0.514 0.636 0.619 0.267 0.560 0.681 0.316 
(0.036) (0.056) (0.086) (0.085) (0.076) (0.118) (0.071) (0.043) (0.110) 
Independent Living 
0.926 0.968 0.943 0.939 0.881 0.800 0.960 0.924 0.842 
(0.019) (0.022) (0.040) (0.042) (0.051) (0.107) (0.028) (0.024) (0.086) 
Employed Full-time 
0.314 0.413 0.171 0.455 0.286 0.000 0.240 0.395 0.000 
(0.034) (0.063) (0.065) (0.088) (0.071) (0.000) (0.061) (0.045) (0.000) 
Employed Part-time 
0.096 0.063 0.086 0.121 0.167 0.000 0.080 0.109 0.053 
(0.022) (0.031) (0.048) (0.058) (0.058) (0.000) (0.039) (0.029) (0.053) 
Retired 
0.356 0.444 0.286 0.333 0.262 0.467 0.340 0.361 0.368 
(0.035) (0.063) (0.077) (0.083) (0.069) (0.133) (0.068) (0.044) (0.114) 












Contributing Manual Nonmanual 
Not 
Working 
(0.027) (0.027) (0.080) (0.042) (0.061) (0.133) (0.063) (0.026) (0.118) 
Not Employed 
0.064 0.032 0.143 0.030 0.095 0.000 0.080 0.050 0.105 
(0.018) (0.022) (0.060) (0.030) (0.046) (0.000) (0.039) (0.020) (0.072) 
Current Income 
$0 - $15,000 
0.240 0.129 0.324 0.133 0.310 0.636 0.271 0.190 0.533 
(0.032) (0.043) (0.081) (0.063) (0.072) (0.152) (0.065) (0.037) (0.133) 
$15,0001 - $30,000 
0.285 0.161 0.382 0.367 0.310 0.364 0.354 0.241 0.400 
(0.034) (0.047) (0.085) (0.089) (0.072) (0.152) (0.070) (0.040) (0.131) 
$30,001 - $50,000 
0.201 0.226 0.147 0.233 0.238 0.000 0.188 0.233 0.000 
(0.030) (0.054) (0.062) (0.079) (0.067) (0.000) (0.057) (0.039) (0.000) 
$50,001 - $75,000 
0.145 0.210 0.147 0.200 0.048 0.000 0.167 0.147 0.067 
(0.026) (0.052) (0.062) (0.074) (0.033) (0.000) (0.054) (0.033) (0.067) 
$75,001 - $100,000 
0.067 0.129 0.000 0.067 0.048 0.000 0.000 0.103 0.000 
(0.019) (0.043) (0.000) (0.046) (0.033) (0.000) (0.000) (0.028) (0.000) 
>$100,000 
0.061 0.145 0.000 0.000 0.048 0.000 0.021 0.086 0.000 
(0.018) (0.045) (0.000) (0.000) (0.033) (0.000) (0.021) (0.026) (0.000) 
Prior Income 
$0 - $15,000 
0.217 0.119 0.286 0.150 0.304 0.429 0.250 0.167 0.500 
(0.038) (0.051) (0.087) (0.082) (0.098) (0.202) (0.078) (0.042) (0.167) 
$15,0001 - $30,000 
0.192 0.071 0.321 0.200 0.174 0.429 0.219 0.167 0.300 
(0.036) (0.040) (0.090) (0.092) (0.081) (0.202) (0.074) (0.042) (0.153) 
$30,001 - $50,000 
0.200 0.190 0.107 0.300 0.261 0.143 0.188 0.218 0.100 
(0.037) (0.061) (0.060) (0.105) (0.094) (0.143) (0.070) (0.047) (0.100) 
$50,001 - $75,000 
0.208 0.167 0.214 0.300 0.261 0.000 0.281 0.205 0.000 
(0.037) (0.058) (0.079) (0.105) (0.094) (0.000) (0.081) (0.046) (0.000) 
$75,001 - $100,000 
0.058 0.143 0.036 0.000 0.000 0.000 0.000 0.090 0.000 
(0.021) (0.055) (0.036) (0.000) (0.000) (0.000) (0.000) (0.033) (0.000) 
>$100,000 
0.125 0.310 0.036 0.050 0.000 0.000 0.063 0.154 0.100 
(0.030) (0.072) (0.036) (0.050) (0.000) (0.000) (0.043) (0.041) (0.100) 
Individual Plan 
0.840 0.859 0.853 0.818 0.810 0.867 0.840 0.833 0.889 
(0.027) (0.044) (0.062) (0.068) (0.061) (0.091) (0.052) (0.034) (0.076) 
Group Plan 
0.074 0.109 0.088 0.061 0.048 0.000 0.040 0.100 0.000 
(0.019) (0.039) (0.049) (0.042) (0.033) (0.000) (0.028) (0.028) (0.000) 
Military/Government 
0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
(0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) (0.000) 
Medicaid 
0.005 0.000 0.000 0.000 0.024 0.000 0.020 0.000 0.000 
(0.005) (0.000) (0.000) (0.000) (0.024) (0.000) (0.020) (0.000) (0.000) 
Medicare 
0.064 0.016 0.029 0.091 0.119 0.133 0.100 0.042 0.111 
(0.018) (0.016) (0.029) (0.051) (0.051) (0.091) (0.043) (0.018) (0.076) 












Contributing Manual Nonmanual 
Not 
Working 
(0.009) (0.016) (0.029) (0.030) (0.000) (0.000) (0.000) (0.014) (0.000) 
DX Diabetes 
0.633 0.641 0.588 0.636 0.619 0.733 0.600 0.650 0.611 
(0.035) (0.060) (0.086) (0.085) (0.076) (0.118) (0.070) (0.044) (0.118) 
DX Cholesterol 
0.888 0.875 0.853 0.970 0.857 0.933 0.880 0.883 0.944 
(0.023) (0.042) (0.062) (0.030) (0.055) (0.067) (0.046) (0.029) (0.056) 
DX Heart Disease 
0.266 0.281 0.265 0.152 0.310 0.333 0.320 0.242 0.278 
(0.032) (0.057) (0.077) (0.063) (0.072) (0.126) (0.067) (0.039) (0.109) 
DX Hypertension 
0.771 0.750 0.824 0.727 0.762 0.867 0.840 0.733 0.833 
(0.031) (0.055) (0.066) (0.079) (0.067) (0.091) (0.052) (0.041) (0.090) 
DX Stroke 
0.080 0.094 0.088 0.030 0.095 0.067 0.100 0.075 0.056 
(0.020) (0.037) (0.049) (0.030) (0.046) (0.067) (0.043) (0.024) (0.056) 
DX Depression 
0.266 0.250 0.235 0.182 0.333 0.400 0.200 0.283 0.333 
(0.032) (0.055) (0.074) (0.068) (0.074) (0.131) (0.057) (0.041) (0.114) 
DX Other Chronic 
Disease 
0.410 0.375 0.471 0.455 0.429 0.267 0.340 0.458 0.278 
(0.036) (0.061) (0.087) (0.088) (0.077) (0.118) (0.068) (0.046) (0.109) 
How Often Prepare 
List of Questions for 
MD (1-6) 
3.250 3.266 2.794 3.182 3.524 3.600 2.800 3.350 3.833 
(0.120) (0.208) (0.242) (0.293) (0.260) (0.456) (0.221) (0.149) (0.406) 
How Often Ask MD 
to Understand 
Treatment (1-6) 
4.293 4.484 4.206 4.121 4.333 3.933 3.880 4.492 4.111 
(0.119) (0.199) (0.283) (0.298) (0.254) (0.408) (0.230) (0.147) (0.378) 
How Often Discuss 
Personal Problems 
with MD Related to 
Illness (1-6) 
3.489 3.563 3.882 3.000 3.405 3.600 3.160 3.575 3.833 
(0.127) (0.224) (0.289) (0.320) (0.273) (0.335) (0.227) (0.167) (0.336) 
Health (1-5; Lower is 
Better) 
3.080 2.969 3.029 2.939 3.310 3.333 3.360 2.950 3.167 
(0.068) (0.126) (0.166) (0.123) (0.134) (0.270) (0.124) (0.084) (0.246) 
Robust standard errors in parentheses 
Correlations between the study variables, specifically job strain and PDC for diabetes and 
statins are shown in Table 4.  Correlation coefficients show that females are less likely to have a 
low strain job.  Active strain is positively correlated with income and education.  Individuals in 
high strain jobs have low adherence to statins.  Lastly, statin adherence is positively correlated 
with adherence to diabetes medications.  
Table 3 continued
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Table 4. Correlations between the Study Variables 
Female Education Current Income Previous Income 
Job Strain PDC 
Active High Strain Low Strain Passive Non-Contributing Diabetes Statins 
Female 1 
Education -0.04 1 
Current Income -0.10 0.47* 1 
Previous Income -0.12 0.30* 0.30* 1 
Job 
Strain 
Active 0.05 0.46* 0.39* 0.31* 1 
High Strain 0.29* -0.21* -0.17* -0.03 -0.34* 1 
Low Strain -0.25* 0.05 -0.04 -0.05 -0.33* -0.22* 1 
Passive -0.15* -0.20* -0.08 -0.17* -0.38* -0.25* -0.25* 1 
Non-Contributing 0.07 -0.25* -0.26* -0.17* -0.21* -0.14 -0.14 -0.16* 1 
PDC 
Diabetes -0.01 0.12 0.05 0.09 0.16 -0.09 0.03 -0.07 -0.08 1 
Statins -0.12 -0.07 0.06 0.10 0.10 -0.18* 0.07 -0.02 0.02 0.49* 1 
*p<0.05
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4.3 PRE-INTERVENTION MODELS 
The pre-intervention models depicting PDC at baseline for job class and job strain are 
presented by medication class. 
4.3.1 Pre-Intervention Models for Job Class 
Table 5 shows baseline PDC as a function of job class with the manual job class as the 
reference category.  The results show significance, although minimal, on adherence for both 
nonmanual workers taking BBs (0.168; p=0.096) and participants prescribed CCBs who are not 
working (-0.307; p=0.096) as compared to the manual job class.  Figure 5 illustrates baseline 
PDC as a function of job class with the manual job class as the reference category as presented in 
Table 5. 
Table 5. Baseline PDC as a Function of Job Class 
Reference Category: 
Manual 




















0.168* -0.152 0.107 0.028 -0.038 0.011 
(0.01) (0.13) (0.09) (0.09) (0.08) (0.060) 
Not Working 
-0.11 -0.307* -0.076 -0.192 -0.118 -0.098 
(0.156) (0.181) (0.127) (0.124) (0.111) (0.086) 
Robust standard errors in parentheses 
*p<0.1
Other covariates not presented here are Age, Female, Nonwhite, Married/Partnered, Diabetes Diagnosis, Cholesterol Diagnosis, Heart 
Disease Diagnosis, Hypertension Diagnosis, Stroke Diagnosis, Depression Diagnosis, Other Diagnosis, Full-time Employment, Part-time 
Employment, Retired, Disabled, Not Employed, Current Income & Prior Income. 
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Figure 5. Baseline PDC as a Function of Job Class 
4.3.2 Pre-Intervention Models for Job Strain 
Table 6 presents baseline PDC as a function of job strain with the reference category as 
the active strain.  The results demonstrate that the non-contributing group has lower adherence 
measured by PDC than the active strain across all medication classes.  In all models post 
estimation calculations were made to compare coefficients to one and other.  Comparing across 
job strain coefficients for the medication class RASA, the low strain (0.174) job type had a 
higher PDC than the non-contributing group (-0.264; p=0.004).  Participants prescribed RASA 
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also showed that the passive strain (-0.082) had a lower PDC than participants with a low strain 
(0.174; p=0.017) job type.  High strain participants (-0.143) had a significantly lower PDC than 
participants with a low strain (0.053; p=0.053) job type for the statin medication class.  Figure 6 
illustrates baseline PDC as a function of job strain with the active job strain as the reference 
category as presented in Table 6.  The results suggest that job strain is strongly associated with 
medication adherence.  
Table 6. Baseline PDC as a Function of Job Strain 
Reference Category: 
Active Strain 






















0.036 -0.033 -0.086 0.049 -0.143* -0.099 
(-0.132) (0.159) (0.106) (0.107) (0.089) (0.071) 
Low Strain 
0.083 -0.007 -0.04 0.174* 0.053* 0.052 
(0.136) (0.173) (0.108) (0.104) (0.09) (0.071) 
Passive 
-0.094 0.024 -0.103 -0.082 -0.041 -0.049 
(0.131) (0.177) (0.096) (0.097) (0.085) (0.068) 
Non-
Contributing 
-0.145 -0.156 -0.228* -0.264*** -0.096 -0.119 
(0.194) (0.197) (0.141) (0.144) (0.126) (0.097) 
Robust standard errors in parentheses 
***p<0.01, *p<0.1 
Other covariates not presented here are Age, Female, Nonwhite, Married/Partnered, Diabetes Diagnosis, Cholesterol Diagnosis, 
Heart Disease Diagnosis, Hypertension Diagnosis, Stroke Diagnosis, Depression Diagnosis, Other Diagnosis, Full-time 
Employment, Part-time Employment, Retired, Disabled, Not Employed, Current Income & Prior Income. 
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Figure 6. Baseline PDC as a Function of Job Strain 
4.4 INTERVENTION MODERATOR MODELS 
The intervention moderator models are used to estimate how job class and job strain 
influence the intervention’s effect on PDC.  The intervention moderator tables present the results 
of five models that show different specifications for covariates as more control variables are 
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included.  The models are noted in each subsequent table with Model 5 being the most robust 
specification (i.e. containing all covariates).  
4.4.1 Intervention Moderator Models for Job Class 
Table 7 shows that job class does not have an impact on the intervention.  Negative 
effects are consistently seen in all models relative to the manual job class (reference category).  
Figure 7 illustrates the moderating effect of job class on the impact of the intervention with the 
manual job class as the reference category as presented in Table 7. 
Table 7. Moderating Effects of Job Class on Impact of Intervention 
Reference Category: 
Manual 
Adjusted ∆ in Proportion Days Covered (PDC) 
Model 1 Model 2 Model 3 Model 4 Model 5 
Job Class 
Nonmanual 
-0.123 -0.135 -0.111 -0.081 -0.072 
(0.083) (0.084) (0.085) (0.084) (0.087) 
Not Working 
-0.12 -0.124 -0.118 -0.16 -0.189 
(0.146) (0.146) (0.147) (0.152) (0.157) 
Robust standard errors in parentheses 
Model 1: Study Group, Job Strain, Baseline PDC;  
Model 2: Model 1 + Age, Female, Nonwhite, Married/Partnered;  
Model 3: Model 2 + High School Degree, Four-year Degree, Professional/Graduate Level Degree, Part-Time Employment, 
Retired, Disabled, Unemployment, Current and Prior Income, Diabetes Diagnosis, Cholesterol Diagnosis, Heart Disease 
Diagnosis, Hypertension Diagnosis, Stroke Diagnosis, Depression Diagnosis, Other Diagnosis;  
Model 4: Model 3 + Group Insurance, Military/Government Insurance, Medicaid Insurance, Health (1-5; Lower is Better), 
Health limited physical activities (1-5; Lower is Better), Bothered by emotional problems (1-5; Lower is Better), Limited 
work in and out of home (1-5; Lower is Better), Interfered with normal social activities (1-5; Lower is Better);  
Model 5: Model 4 + How Often Prepare List of Questions for MD (1-6), How Often Ask MD to Understand Treatment (1-
6), How Often Discuss Personal Problems with MD Related to Illness (1-6). 
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Figure 7. Moderating Effects of Job Class on Impact of Intervention 
4.4.2 Intervention Moderator Models for Job Strain 
Changes in PDC in response to the intervention are positively moderated by all job 
strains, except non-contributing, relative to the active strain as shown in Table 8.  The low strain 
job type has the largest moderating effect of the intervention (p<0.01) with an effect estimate 
range from 0.169 (p<0.01) to 0.202 (p<0.01).  Additionally, the moderating effect for the high 
strain job type in Model 4 is positive and significant (0.172; p<0.1).  Model five, the most robust 
specification, yields a 0.181 adjusted change in PDC or 18.1 percentage point increase in PDC 
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for the low strain job type.  Figure 8 illustrates the moderating effect of job strain on the impact 
of the intervention with the active job strain as the reference category as presented in Table 8.  
The results of the intervention moderator models demonstrate that job strain is associated with 
the impact of the intervention. 
Table 8. Moderating Effects of Job Strain on Impact of Intervention 
Reference Category: 
Active Strain 
Adjusted ∆ in Proportion Days Covered (PDC) 
Model 1 Model 2 Model 3 Model 4 Model 5 
Job Strain 
High Strain 
0.114 0.111 0.125 0.172* 0.141 
(0.082) (0.087) (0.093) (0.096) (0.097) 
Low Strain 
0.179*** 0.169*** 0.202*** 0.178*** 0.181*** 
(0.062) (0.06) (0.052) (0.054) (0.051) 
Passive 
0.144 0.146 0.134 0.135 0.147 
(0.108) (0.109) (0.111) (0.098) (0.101) 
Non-Contributing 
0.063 0.075 0.059 -0.028 -0.021 
(0.154) (0.152) (0.156) (0.193) (0.191) 
Robust standard errors in parentheses 
***p<0.01, *p<0.1 
Model 1: Study Group, Job Strain, Baseline PDC;  
Model 2: Model 1 + Age, Female, Nonwhite, Married/Partnered;  
Model 3: Model 2 + High School Degree, Four-year Degree, Professional/Graduate Level Degree, Part-Time Employment, 
Retired, Disabled, Unemployment, Current and Prior Income, Diabetes Diagnosis, Cholesterol Diagnosis, Heart Disease 
Diagnosis, Hypertension Diagnosis, Stroke Diagnosis, Depression Diagnosis, Other Diagnosis;  
Model 4: Model 3 + Group Insurance, Military/Government Insurance, Medicaid Insurance, Health (1-5; Lower is Better), 
Health limited physical activities (1-5; Lower is Better), Bothered by emotional problems (1-5; Lower is Better), Limited 
work in and out of home (1-5; Lower is Better), Interfered with normal social activities (1-5; Lower is Better);  
Model 5: Model 4 + How Often Prepare List of Questions for MD (1-6), How Often Ask MD to Understand Treatment (1-6), 
How Often Discuss Personal Problems with MD Related to Illness (1-6). 
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Figure 8. Moderating Effects of Job Strain on Impact of Intervention 
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5.0 DISCUSSION 
Table 9 summarizes the main findings of this research study and these findings are 
presented in the subsequent sections of this discussion section. 
Table 9. Main Findings 
Pre-Intervention Models Intervention Moderator Models 
Job Class Job Strain Job Class Job Strain 
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5.1 PRE-INTERVENTION MODELS 
The pre-intervention models of the association of PDC at baseline revealed that job strain 
is correlated with medication adherence, while job class, classically defined as manual (blue-
collar), nonmanual (white-collar), and not working (retired, disabled, and unemployed), does not 
have a strong association with medication adherence.  Comparing across post-hoc testing for job 
strain in the RASA and statin medication classes, the low strain job type has a more positive 
association with PDC then both the high strain job type and passive job type, followed by the 
non-contributing group.  
Based on other literature, individuals in the high strain classification have the poorest 
health, where demands are high, but the employee’s ability to use skill or authority to address 
these demands are low (Amick III et al., 1998; de Jonge, Dollard, Dormann, Le Blanc, & 
Houtman, 2000; Lerner et al., 1994; Lewchuk, Clarke, & De Wolff, 2008; Stansfeld & Candy, 
2006; Theorell et al., 1988; Vermeulen & Mustard, 2000).  The results of the present study are 
consistent with this literature and add to it by providing evidence that health behaviors, in this 
case medication adherence, may be a key factor in deteriorating health.   
The results imply several possible hypotheses.  Individuals in a high strain job type have 
very little autonomy and so perhaps over time they are being conditioned to be passive 
participants in their health.  If such a hypothesis were true, then providing an intervention 
tailored to high strain occupations may help people manage their health behaviors, specifically 
improving their adherence to a prescribed medication regimen. Such hypotheses also 
recommend innovative strategies to be explored.  For example, an employer might offer rotations 
through different job activities in an effort to foster job autonomy.  However, it must be noted 
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that hypotheses based on these results alone face a major challenge from selection bias.  Given 
that the results are cross-sectional, it cannot be ruled out that unobserved individual 
characteristics resulting from an individual’s life experiences may lead to both high strain 
occupations and lower adherence.  Such a scenario reduces the impact of the intervention 
described above.  Regardless of selection bias, though, the finding of high strain occupations as a 
risk factor for low adherence still remains viable. 
Individuals of the non-contributing group are people who, even after controlling for 
education and income, have potential unobserved characteristic(s) that lead to poor adherence 
and not being active members of the labor market.  In terms of public health significance, a lack 
of job status or a certain type of job status could be a key indicator for developing an alternative 
intervention. 
An alternative to this logic may be that job stress or job strain leads to low medication 
adherence.  For example, an individual in the non-contributing group (retired, disabled, or not 
working) may have stress in their daily life, which causes extreme anxiety.  This anxiety may 
lead to the individual not working and consequently, an inability to obtain their prescribed 
medication regimen.  Perhaps the non-contributing group produces stress factors that are not 
explicit, however these factors fit the model, indicating that stress is a predictor of low 
medication adherence.  Additional analyses can attempt to discern whether it is the unobserved 
part of an individual or the lack of engagement in the labor market that causes low medication 
adherence. The latter may be ameliorated by interventions focusing on physical and 
psychological stressors.  
The positive association with adherence for low strain job types (low psychological 
demand, high decision latitude) seems to allow participants with this job strain the capability to 
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modify their health behavior.  Traditionally, low strain occupations have been characterized as 
“healthier” job types (Lerner et al., 1994).  Characterized by the Occupational Distribution of 
Psychosocial Job Characteristics, examples of low strain job types are a dentist, lineman, natural 
scientist, and architect (Appendix C).  In addition to low psychological demand and high 
decision latitude or high job control, low strain occupations may provide a fairly secure work 
schedule, decreased physical stress, and decreased psychological stress.   
In summary, job class is not correlated with medication adherence.  However, job strain 
is constructed in a manner that more accurately correlates occupation with medication adherence.  
Individuals with a low strain job type adhere to their medication regimen, while the high strain, 
passive, and non-contributing groups are most at risk for poor medication adherence.  Further 
analysis of these job types with respect to tailored interventions may reveal ways to improve 
medication adherence and other health behaviors.   
5.2 INTERVENTION MODERATOR MODELS 
The intervention moderator models demonstrate how job class and job strain influence 
the intervention effect (SBI + pillbox) on PDC.  Model estimates show that job class does not 
have an effect on the intervention.  However, job strain influences the intervention effect on PDC 
and the effect is different across job strains.   
The low strain job type demonstrates a substantially high response on the intervention 
effect across all models.  Model five, the most robust specification, yields a 0.181 adjusted 
change in PDC or 18.1 percentage point increase in PDC.  This increase reveals a strong 
association between job strain and medication adherence.  It can be interpreted that individuals in 
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low strain occupations have the ability to process information as a result of an intervention and 
positively adhere to health behaviors that promote their wellness.    
High strain job types demonstrate a significant effect on the intervention in Model 4, 
which includes specifications on insurance and other health behaviors.  In this instance, high 
strain job types are similar to low strain job types in health behaviors with respect to the 
following: health limited physical activities, bothered by emotional problems, limited work in 
and out of home, interfered with normal social activities. 
One of the challenges in examining medication adherence is that a ceiling effect exists.  
That is if an individual has 0.9 PDC, they can only improve 10 percentage points or by 0.1 PDC.  
Whereas if someone has 0.3 PDC, they can undergo a greater improvement of 0.7 PDC.  The 
results presented in Table 8 indicate that the high strain job type has overall low adherence, and 
therefore can undergo a large improvement in their adherence with respect to the intervention.  
The low strain job type exhibited high PDC, yet the low strain job type improved by 0.18 PDC.  
This strengthens the interpretation that low job strain indeed produces a moderating effect and 
the effect is not an artifact of the mathematics in determining PDC.   
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6.0  SUMMARY 
The objective of this dissertation was to examine the relationship between occupational 
factors and health behaviors.  The primary new finding is job strain is correlated with medication 
adherence.  A positive association exists between adherence and low strain job types, which offer 
low psychological demand with high decision latitude or high job control and provide a fairly 
stable work schedule, decreased physical stress, and decreased psychological stress.  Several 
possible hypotheses implied by these results are that such occupational conditions reinforce job 
autonomy in participants and allow the mental aptitude needed to modify their health behaviors.  
Therefore, a stable psychological well-being may lead to the promotion of an individual’s self-
efficacy in performing positive health behaviors (i.e. medication adherence). 
6.1 LIMITATIONS 
A challenge to such hypotheses is selection bias.  Individuals with certain characteristics 
(e.g. high self-efficacy) may simply choose both low-strain occupations and have a propensity 
for high adherence.  The second part of this study avoids some of the challenge of selection bias 
since it looked at participants over time and in conjunction with an intervention.  Both the pre-
intervention models and intervention moderator models reveal that job class is not correlated 
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with medication adherence.  However, the pre-intervention models and intervention moderator 
models demonstrate a strong association between job strain and medication adherence.   
Additionally, sample selection was also a limitation in the study design.  The RCT 
provided a convenient sample of individuals presenting with certain criteria at community 
pharmacies.  Among those who received the occupational health questionnaire, approximately 
50% of the sample responded and had other data sources available to be matched to them, 
respectively.  The sample responding to the questionnaire did not differ from the RCT sample by 
age, gender, pharmacy, or study treatment groups.  However, it is likely that unobserved 
characteristics exist for participants who responded to the questionnaire versus those who did 
not.  For example, participants that responded might be healthier, more educated and higher 
functioning.  Overall, this represents a threat to the external validity of the study results.  
Nonetheless, this is a prospective research study that has utilized a unique and difficult to obtain 
data set, describing characteristics about job type and health behaviors such as adherence.  This 
study sample brings to light new information on the relationship between occupational history 
and medication adherence.  Ideally, future work should be continued to build on the results of 
this study by assessing more representative samples to corroborate and expand this new 
knowledge.   
6.2 STRENGTHS 
This study also had several important strengths in its design.  First, this is an innovative 
study that analyzes job class and job strain and its effect on medication adherence.  
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Administrative insurance claims data were used, which is considered an established approach in 
assessing medication adherence.   
Additionally, GLMM was used to efficiently model repeated measures within individual 
participants and clustering within pharmacies.  This statistical framework was able to 
successfully handle any abnormalities in the distribution of the dependent variable (PDC).  
Ultimately, treating the dependent variable as linear or continuous was the best fit for the 
distribution of the data.   
Lastly, a well-established model was utilized in discerning job strain for various self-
reported job types.  The Karasek demand-control model is a widely accepted model used to 
measure the psychological demands of a job and the worker’s ability to use skills or authority to 
address those demands (i.e. decision latitude).  The model has been found to predict several 
adverse health outcomes, specifically CVD. 
6.3 NEXT STEPS 
The results of this study reveal that job strain should be considered in strategizing 
occupation-specific interventions for improving medication adherence.  By examining an 
established and widely accepted model in characterizing job strain, employers can utilize this 
methodology in assessing their own workplace population.  This information can then be used to 
develop occupation-specific interventions using passive (e.g. pillbox) and active approaches (e.g. 
SBI, interactive module, web-based application) for implementation into a disease management 
component of a workplace wellness program.  A return on investment analysis can then be 
conducted to assess healthcare costs.  Development of occupation-specific interventions 
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designed to improve medication adherence in individuals with chronic disease can contribute to a 
new body of knowledge aimed at reducing healthcare costs.  
  Additionally, the results of this study recommend new areas of targeted research on 
interventions and health behaviors.  Future studies should aim to evaluate data on health 
behaviors.  For example, based on job type, to what extent does an individual’s involvement in 
their healthcare (e.g. how often an individual prepares a list of questions for the physician) 
influence their ability to successfully perform health behaviors (e.g. medication adherence) to 
reach a desired health outcome.  This information would serve to enhance the relationship 
between occupational factors and medication adherence.  
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APPENDIX A: OCCUPATIONAL HEALTH QUESTIONNAIRE 
Dear Participant, 
We appreciate your participation in the Eco-Phil study.  The purpose of this mailing is to 
request that you provide answers to additional questions that will help to determine if 
occupational history effects the ability to take medication.   
Your voluntary completion of these questions and subsequent mailing back to the University 
of Pittsburgh indicates your agreement to provide this information.  This information is very 
important to the results of the study.  Your responses will only be linked to the code number 
on this letter, so in order to protect your privacy, please do not put your name on this letter.   
A return postage-stamped envelope is provided to further secure your privacy. 
1. What is your Job Title (Occupation) OR if not working, what was your most recent Job Title?
_______________________________________________________________________
2. What is your Job setting (work location) OR if not working, what was your most recent setting?
______________________________________________________________________
3. What is your current approximate gross annual household income AND your prior annual
household income if unemployed, disabled, or retired)?  Please include ALL household
members and ALL income sources (wages, child support, alimony, income from assets,
disability, unemployment compensation, public assistance, and pensions, social security and
other retirement income).
CURRENT INCOME 
O $0 – 15,000 
O $15,001 - $30,000 
O $30,001 - $50,000 
O $50,001 - $75,000 
O $75,001 - $100,000 
O more than $100,000 
PRIOR INCOME  
(if unemployed, disabled, or retired) 
O $0 – 15,000 
O $15,001 - $30,000 
O $30,001 - $50,000 
O $50,001 - $75,000 
O $75,001 - $100,000 
O more than $100,000 
O Not Applicable 
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To: Janice Pringle 
From: Christopher Ryan  Vice Chair
Date: 10/2/2013
IRB#: MOD12050040-03  / PRO12050040
Subject: Prospective Study on a Pharmacist-led Intervention to Improve Medication Adherence
The University of Pittsburgh Institutional Review Board reviewed and approved the requested modifications by
expedited review procedure authorized under 45 CFR 46.110 and 21 CFR 56.110.
The IRB has approved the waiver for the requirement to obtain a written informed consent.
Modification Approval Date: 10/2/2013
Expiration Date: 4/1/2014
For studies being conducted in UPMC facilities, no clinical activities that are impacted by the modifications can be
undertaken by investigators until they have received approval from the UPMC Fiscal Review Office.
Please note that it is the investigator’s responsibility to report to the IRB any unanticipated problems involving risks to
subjects or others [see 45 CFR 46.103(b)(5) and 21 CFR 56.108(b)]. Refer to the IRB Policy and Procedure Manual
regarding the reporting requirements for unanticipated problems which include, but are not limited to, adverse events. 
If you have any questions about this process, please contact the Adverse Events Coordinator at 412-383-1480 .
The protocol and consent forms, along with a brief progress report must be resubmitted at least one month prior to the
renewal date noted above as required by FWA00006790 (University of Pittsburgh), FWA00006735 (University of
Pittsburgh Medical Center), FWA00000600 (Children’s Hospital of Pittsburgh), FWA00003567 (Magee-Womens
Health Corporation), FWA00003338 (University of Pittsburgh Medical Center Cancer Institute).
Please be advised that your research study may be audited periodically by the University of Pittsburgh Research
Conduct and Compliance Office.
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Labels for forty seven occupations could not be printed
due to lack of space (computer based label routine).
FIGURE 1-The Occupational Distribution of Psychosocal Job Characteristics









summary measures were computed across the age groups,
the estimated odds were 2.48 (chi-square MH = 6.32, p =
.012) and 3.28 (chi-square MH = 10.18, p = .001), respec-
tively, for the HES and HANES. Using the overall rate of
"high strain" and the estimates of the underlying odds, the
estimated attributable risk is .25 and .33, respectively, for the
HES and the HANES. While this analysis fails to control for
many important factors in myocardial infarction (e.g., race,
blood pressure, cholesterol and smoking status), it is striking
that controlling for age alone, "job strain" accounts for
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Table 10. Pairwise T-Tests by Job Class and Job Strain 
Variable Description 
Significant Observations (p<0.05), (p<0.1) 
Job Class Job Strain 
pdcmbb1 
Proportion Days Covered 
(PDC) for beta blockers (BB) 
medication class post-
intervention 
 Low Strain (.9156) vs. High
Strain (.5731); p=0.0230
pdcmraas0 
Proportion Days Covered 
(PDC) for renin angiotensin 
system antagonists (RASA) 
medication class pre-
intervention 
 Low Strain (.8668) vs.
Active (.6435); p=0.0076
 Low Strain (.8668) vs.
Passive (.5629); p=0.0020




Proportion Days Covered 
(PDC) for statins medication 
class pre-intervention 
 Active (.6452) vs. High
Strain (.4681); p=0.0230
 Low Strain (.6555) vs. High
Strain (.4681); p=0.0534
pdc80bb0 
Proportion Days Covered 
>80% (PDC80) for beta 
blockers (BB) medication 
class pre-intervention 
 Nonmanual (.6512) vs
Manual (.3846); p=0.0312
pdc80ccb0 
Proportion Days Covered 
>80% (PDC80) for calcium 
channel blockers (CCB) 
medication class pre-
intervention 
 Active (.7273) vs. High
Strain (.3125); p=0.0102
 Low Strain (.875) vs. High
Strain (.3125); p=0.0077
pdc80raas0 
Proportion Days Covered 





 Low Strain (.75) vs. Non-
Contributing (.3); p=0.0168
mdage Age 
 Not Working (65.78) vs.
Manual (60.26); p=0.0596




 Nonmanual (.625) vs.
Manual (.28); p=0.0000
 Not Working (.7222) vs.
Manual (.28); p=0.0008
 High Strain (.8529) vs.
Active (.5781); p=0.0054
 Active (.5781) vs. Low
Strain (.2727); p=0.0040
 High Strain (.8529) vs. Low
Strain (.2727); p=0.0000
 High Strain (.8529) vs.
Passive (.4047); p=0.0000
 Non-contributing (.6667)
vs. Low Strain (.2727);
p=0.0089
mdedm1 
Individual has less than a high 
school degree 
 Manual (.3) vs. Nonmanual
(.0756); p=0.0001
 Not Working (.4737) vs.
Nonmanual (.0756);
p=0.0000
 High Strain (.3143) vs.
Active (.0476); p=0.0002










Significant Observations (p<0.05), (p<0.1) 
Job Class Job Strain 






Individual has a high school 
degree 
 Manual (.5) vs. Nonmanual
(.1849); p=0.0000
 Low Strain (.3636) vs.
Active (.1429); p=0.0126
 Passive (.4286) vs. Active
(.1429); p=0.0009
mdedm3 
Individual has a four-year 
degree 
 Nonmanual (.3529) vs.
Manual (.12); p=0.0020
mdedm4 
Individual has a 
professional/graduate level 
degree 
 Active (.5556) vs. High
Strain (.0857); p=0.0000
 Active (.5556) vs. Low
Strain (.2424); p=0.0031
 Active (.5556) vs. Passive
(.0952); p=0.0000
 Active (.5556) vs. Non-
Contributing (0); p=0.0001
 Low Strain (.2424) vs. Non-
Contributing (0); p=0.0373
 Nonmanual (.3866) vs.
Manual (.08); p=0.0001





 Nonmanual (.6807) vs. Not
Working (.3158); p=0.0020
 Active (.7302) vs. High
Strain (.5149); p=0.0316
 Active(.7302) vs. Non-
Contributing (.2667);
p=0.0006
 Low Strain (.6364) vs. Non-
Contributing (.2667);
p=0.0170
 Passive (.6191) vs. Non-
Contributing (.2667);
p=0.0186
mdlivhom Independent living 
 Active (.9683) vs. Passive
(.8809); p=0.0803
 Active (.9683) vs. Non-
Contributing (.8); p=0.0165
mdemp1 Employed full-time 
 Nonmanual (.3949) vs.
Manual (.24); p=0.0542
 Manual (.24) vs. Not
Working (0); p=0.0185
 Nonmanual (.3949) vs. Not
Working (0); p=0.0006
 Active (.4127) vs. High
Strain (.1714); p=0.0144
 Active (.4127)  vs. Non-
Contributing (0); p=0.0020
 Low Strain (.4545) vs. High
Strain (.1714); p=0.0111
 Low Strain (.4545) vs. Non-
Contributing (0); p=0.0012
 Passive (.2857) vs. Non-
Contributing (0); p=0.0195
mdemp3 Retired 
 Active (.4444) vs. Passive
(.2619); p=0.0587
mdemp4 Disabled 
 Manual (.26) vs.
Nonmanual (.0840);
p=0.0022
 Not working (.4737) vs.
Nonmanual (.0840);
p=0.0000
 High Strain (.3142)vs.
Active (.0476); p=0.0002









Significant Observations (p<0.05), (p<0.1) 
Job Class Job Strain 
Strain (.0606); p=0.0073 
 Non-Contributing (.5333)





mdemp5 Not employed 
 High Strain (.1429) vs.
Active (.0317); p=0.0411
incc1 
Current income between $0 - 
$15,000 
 Not Working (.5333) vs.
Nonmanual (.1897);
p=0.0027
 High Strain (.3235) vs.
Active (.1290); p=0.0221












Current income between 
$15,001 - $30,000 
 High Strain (.3824) vs.
Active (.1613); p=0.0150
 Low Strain (.3667) vs.
Active (.1613); p=0.0278
incc3 
Current income between 
$30,001 - $50,000 
 Nonmanual (.2328) vs. Not
Working (0); p=0.0362
incc4 
Current income between 
$50,001-$75,000 
 Active (.2097) vs, Passive
(.0476); p=0.0209
 Low Strain (.2) vs. Passive
(.0476); p=0.0431
incc5 
Current income between 
$75,001-$100,000 
 Nonmanual (.1034) vs.
Manual (0); p=0.0206
 Active (.1290) vs. High
Strain (0); p=0.0288
incc6 
Prior income is more than 
$100,000 
 Active (.0451) vs. High
Strain (0); p=0.0194
 Active (.0451) vs. Low
Strain (0); p=0.0281
incp1 
Prior income is between $0 - 
$15,000 







Prior income is between 
$15,001 - $30,000 






Prior income is between 
$75,001 - $100,000 
 Active (.1429) vs. Passive
(0); p=0.0584
incp6 
Prior income is more than 
$100,000 
 High Strain (.0357) vs.
Active (.3095); p=0.0045
 Active (.3095) vs. Low
Strain (.05); p=0.0222
 Active (.3095) vs. Passive
(0); p=0.0024
mdbins5 Insured via Medicare 






Significant Observations (p<0.05), (p<0.1) 
Job Class Job Strain 
vs. Active (.0156); 
p=0.0320 
mddrqs1 
When you visit your doctor, 
how often do you prepare a 
list of questions for your 
doctor? 
 Nonmanual (3.35) vs.
Manual (2.8); p=0.0439
 Not Working (3.833) vs.
Manual (2.8); p=0.0224
 Passive (3.524) vs. High
Strain (2.794); p=0.0474
mddrqs2 
When you visit your doctor, 
how often do you ask 
questions about the things you 
don’t understand about your 
treatment? 
 Nonmanual (4.492) vs.
Manual (3.88); p=0.0256
mddrqs3 
When you visit your doctor, 
how often do you discuss any 
personal problems that may 
be related to your illness? 
 High Strain (3.882) vs. Low
Strain (3); p=0.0443
mdhealth 
In general, you would say 
your health is? 
 Manual (3.36) vs.
Nonmanual (2.95);
p=0.0078





AbuSabha, R., & Achterberg, C. (1997). Review of self-efficacy and locus of control for 
nutrition-and health-related behavior. Journal of the American Dietetic Association, 
97(10), 1122-1132.  
Amick III, B. C., Kawachi, I., Coakley, E. H., Lerner, D., Levine, S., & Colditz, G. A. (1998). 
Relationship of job strain and iso-strain to health status in a cohort of women in the 
United States. Scandinavian journal of work, environment & health, 54-61.  
Baicker, K., Cutler, D., & Song, Z. (2010). Workplace wellness programs can generate savings. 
Health Affairs, 10.1377/hlthaff. 2009.0626.  
Bandura, A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychological 
review, 84(2), 191.  
Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory: 
Prentice-Hall, Inc. 
Bandura, A. (1990). Perceived self-efficacy in the exercise of control over AIDS infection. 
Evaluation and program planning, 13(1), 9-17.  
Bandura, A. (1997). Self-efficacy: The exercise of control: Macmillan. 
Baron, R. M., & Kenny, D. A. (1986). The moderator–mediator variable distinction in social 
psychological research: Conceptual, strategic, and statistical considerations. Journal of 
personality and social psychology, 51(6), 1173.  
Belkic, K. L., Landsbergis, P. A., Schnall, P. L., & Baker, D. (2004). Is job strain a major source 
of cardiovascular disease risk? Scandinavian journal of work, environment & health, 85-
128.  
Bijl, R., Van Zessen, G., Ravelli, A., De Rijk, C., & Langendoen, Y. (1998). The Netherlands 
mental health survey and incidence study (NEMESIS): objectives and design. Social 
psychiatry and psychiatric epidemiology, 33(12), 581-586.  
Blair, S. N., Jacobs Jr, D. R., & Powell, K. E. (1985). Relationships between exercise or physical 
activity and other health behaviors. Public health reports, 100(2), 172. 
Bodenheimer, T., Chen, E., & Bennett, H. D. (2009). Confronting the growing burden of chronic 
disease: can the US health care workforce do the job? Health Affairs, 28(1), 64-74.  
Bray, J. W., Zarkin, G. A., Miller, W. R., Mitra, D., Kivlahan, D. R., Martin, D. J., . . . Cisler, R. 
A. (2007). Measuring Economic Outcomes of Alcohol Treatment Using the Economic 
Form 90*. Journal of studies on alcohol and drugs, 68(2), 248-255.  
Brown, M. T., & Bussell, J. K. (2011). Medication adherence: WHO cares? Paper presented at 
the Mayo Clinic Proceedings. 
67 
Caloyeras, J. P., Liu, H., Exum, E., Broderick, M., & Mattke, S. (2014). Managing manifest 
diseases, but not health risks, saved PepsiCo money over seven years. Health Affairs, 
33(1), 124-131.  
Carls, G. S., Roebuck, M. C., Brennan, T. A., Slezak, J. A., Matlin, O. S., & Gibson, T. B. 
(2012). Impact of medication adherence on absenteeism and short-term disability for five 
chronic diseases. Journal of Occupational and Environmental Medicine, 54(7), 792-805.  
Clark, N. M., & Dodge, J. A. (1999). Exploring self-efficacy as a predictor of disease 
management. Health Education & Behavior, 26(1), 72-89.  
Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007). Psychological stress and disease. Jama, 
298(14), 1685-1687.  
Cohen, S., Kessler, R. C., & Gordon, L. U. (1995). Strategies for measuring stress in studies of 
psychiatric and physical disorders. Measuring stress: A guide for health and social 
scientists, 3-26.  
Collins, S. M., Karasek, R. A., & Costas, K. (2005). Job strain and autonomic indices of 
cardiovascular disease risk. American journal of industrial medicine, 48(3), 182-193. 
Cooper, C. L., & Cartwright, S. (1994). Healthy mind; healthy organization—A proactive 
approach to occupational stress. Human relations, 47(4), 455-471.  
de Jonge, J., Dollard, M. F., Dormann, C., Le Blanc, P. M., & Houtman, I. L. (2000). The 
demand-control model: Specific demands, specific control, and well-defined groups. 
International Journal of Stress Management, 7(4), 269-287.  
De Lange, A. H., Taris, T. W., Kompier, M. A., Houtman, I. L., & Bongers, P. M. (2003). " The 
very best of the millennium": longitudinal research and the demand-control-(support) 
model. Journal of occupational health psychology, 8(4), 282.  
DeLongis, A., Folkman, S., & Lazarus, R. S. (1988). The impact of daily stress on health and 
mood: psychological and social resources as mediators. Journal of personality and social 
psychology, 54(3), 486.  
Dhabhar, F. S., & Mcewen, B. S. (1997). Acute stress enhances while chronic stress suppresses 
cell-mediated immunityin vivo: A potential role for leukocyte trafficking. Brain, 
behavior, and immunity, 11(4), 286-306.  
DiClemente, C. C., Fairhurst, S. K., & Piotrowski, N. A. (1995). Self-efficacy and addictive 
behaviors Self-efficacy, adaptation, and adjustment (pp. 109-141): Springer. 
Diestel, S., & Schmidt, K.-H. (2009). Mediator and moderator effects of demands on self-control 
in the relationship between work load and indicators of job strain. Work & Stress, 23(1), 
60-79.  
Dimatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and 
medical treatment outcomes: a meta-analysis. Medical care, 40(9), 794-811. 
Goetzel, R. Z., Long, S. R., Ozminkowski, R. J., Hawkins, K., Wang, S., & Lynch, W. (2004). 
Health, absence, disability, and presenteeism cost estimates of certain physical and 
mental health conditions affecting US employers. Journal of Occupational and 
Environmental Medicine, 46(4), 398-412.  
Goldberg, P., Gueguen, A., Schmaus, A., Nakache, J., & Goldberg, M. (2001). Longitudinal 
study of associations between perceived health status and self reported diseases in the 
French Gazel cohort. Journal of Epidemiology and Community Health, 55(4), 233-238.  
Grau, R., Salanova, M., & Peiro, J. M. (2001). Moderator effects of self-efficacy on occupational 
stress. Psychology in Spain, 5(1), 63-74. 
68 
Häusser, J. A., Mojzisch, A., Niesel, M., & Schulz-Hardt, S. (2010). Ten years on: A review of 
recent research on the Job demand–control (-Support) model and psychological well-
being. Work & Stress, 24(1), 1-35.  
Hellerstedt, W. L., & Jeffery, R. W. (1997). The association of job strain and health behaviours 
in men and women. International Journal of Epidemiology, 26(3), 575-583. 
Herrick, A. B., Stone, W. J., & Mettler, M. M. (1997). Stages of change, decisional balance, and 
self-efficacy across four health behaviors in a worksite environment. American Journal of 
Health Promotion, 12(1), 49-56.  
Houtman, I., Kornitzer, M., De Smet, P., Koyuncu, R., De Backer, G., Pelfrene, E., . . . Origgi, 
G. (1999). Job stress, absenteeism and coronary heart disease European cooperative study 
(the JACE study): design of a multicentre prospective study. The European Journal of 
Public Health, 9(1), 52-57.  
Iuga, A. O., & McGuire, M. J. (2014). Adherence and health care costs. Risk management and 
healthcare policy, 7, 35.  
Jex, S. M., & Bliese, P. D. (1999). Efficacy beliefs as a moderator of the impact of work-related 
stressors: a multilevel study. Journal of applied Psychology, 84(3), 349.  
Jex, S. M., & Gudanowski, D. M. (1992). Efficacy beliefs and work stress: An exploratory study. 
Journal of Organizational Behavior, 13(5), 509-517.  
Judge, T. A., & Bono, J. E. (2001). Relationship of core self-evaluations traits—self-esteem, 
generalized self-efficacy, locus of control, and emotional stability—with job satisfaction 
and job performance: A meta-analysis. Journal of applied Psychology, 86(1), 80.  
Karasek Jr, R. A. (1979). Job demands, job decision latitude, and mental strain: Implications for 
job redesign. Administrative science quarterly, 285-308. 
Karasek, R., Baker, D., Marxer, F., Ahlbom, A., & Theorell, T. (1981). Job decision latitude, job 
demands, and cardiovascular disease: a prospective study of Swedish men. American 
journal of public health, 71(7), 694-705.  
Karasek, R., Collins, S., Clays, E., Bortkiewicz, A., & Ferrario, M. (2010). Description of a 
large-scale study design to assess work-stress-disease associations for cardiovascular 
disease. International journal of occupational medicine and environmental health, 23(3), 
293-312.  
Karasek, R. A., Theorell, T., Schwartz, J. E., Schnall, P. L., Pieper, C. F., & Michela, J. L. 
(1988). Job characteristics in relation to the prevalence of myocardial infarction in the US 
Health Examination Survey (HES) and the Health and Nutrition Examination Survey 
(HANES). American journal of public health, 78(8), 910-918.  
Kelly, R. B., Zyzanski, S. J., & Alemagno, S. A. (1991). Prediction of motivation and behavior 
change following health promotion: Role of health beliefs, social support, and self-
efficacy. Social science & medicine, 32(3), 311-320.  
Kivimäki, M., Nyberg, S. T., Batty, G. D., Fransson, E. I., Heikkilä, K., Alfredsson, L., . . . 
Casini, A. (2012). Job strain as a risk factor for coronary heart disease: a collaborative 
meta-analysis of individual participant data. The Lancet, 380(9852), 1491-1497.  
Kobau, R., & DiIorio, C. (2003). Epilepsy self-management: a comparison of self-efficacy and 
outcome expectancy for medication adherence and lifestyle behaviors among people with 
epilepsy. Epilepsy & Behavior, 4(3), 217-225.  
Kotecha, D., Manzano, L., Altman, D. G., Krum, H., Erdem, G., Williams, N., & Flather, M. D. 
(2013). Individual patient data meta-analysis of beta-blockers in heart failure: rationale 
and design. Systematic reviews, 2(1), 1-10.  
69 
Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence 
in chronic medical conditions: a systematic review. Archives of internal medicine, 167(6), 
540-549.  
Landsbergis, P. A., Schnall, P. L., Schwartz, J. E., Warren, K., & Pickering, T. G. (1995). Job 
strain, hypertension, and cardiovascular disease: Empirical evidence, methodological 
issues, and recommendations for further research.  
Lerner, D. J., Levine, S., Malspeis, S., & D'Agostino, R. B. (1994). Job strain and health-related 
quality of life in a national sample. American journal of public health, 84(10), 1580-
1585.  
Lewchuk, W., Clarke, M., & De Wolff, A. (2008). Working without commitments: precarious 
employment and health. Work, Employment & Society, 22(3), 387-406.  
Loeppke, R., Haufle, V., Jinnett, K., Parry, T., Zhu, J., Hymel, P., & Konicki, D. (2011). 
Medication adherence, comorbidities, and health risk impacts on workforce absence and 
job performance. Journal of Occupational and Environmental Medicine, 53(6), 595-604.  
Luszczynska, A., Sarkar, Y., & Knoll, N. (2007). Received social support, self-efficacy, and 
finding benefits in disease as predictors of physical functioning and adherence to 
antiretroviral therapy. Patient Education and Counseling, 66(1), 37-42.  
Marks, R., & Allegrante, J. P. (2005). A review and synthesis of research evidence for self-
efficacy-enhancing interventions for reducing chronic disability: implications for health 
education practice (part II). Health promotion practice, 6(2), 148-156.  
Martins, R. K., & McNeil, D. W. (2009). Review of motivational interviewing in promoting 
health behaviors. Clin Psychol Rev, 29(4), 283-293. 
Mattke, S., Liu, H., Caloyeras, J., Huang, C. Y., Van Busum, K. R., Khodyakov, D., & Shier, V. 
(2013). Workplace wellness programs study. Rand Corporation.  
Mattke, S., Schnyer, C., & Van Busum, K. (2012). A review of the US workplace wellness 
market: Rand Health. 
McCulloch, C. E., & Neuhaus, J. M. (2005). Generalized Linear Mixed Models Encyclopedia of 
Biostatistics: John Wiley & Sons, Ltd. 
Miller, W. R., & Rollnick, S. (2002). Motivational interviewing : preparing people for change 
(2nd ed.). New York: Guilford Press. 
Network for Excellence in Health Innovation. (2011). Bend the Curve: Health Care Leader's 
Guide to High Value Health Care. 
Ng, D. M., & Jeffery, R. W. (2003). Relationships between perceived stress and health behaviors 
in a sample of working adults. Health Psychology, 22(6), 638.  
O'Leary, A. (1985). Self-efficacy and health. Behaviour research and therapy, 23(4), 437-451.  
Osterberg, L., & Blaschke, T. (2005). Adherence to Medication. New England Journal of 
Medicine, 353(5), 487-497. doi: doi:10.1056/NEJMra050100 
Pelfrene, E., Vlerick, P., Mak, R. P., De Smet, P., Kornitzer, M., & De Backer, G. (2001). Scale 
reliability and validity of the Karasek'Job Demand-Control-Support'model in the 
Belstress study. Work & Stress, 15(4), 297-313.  
Petersen, R., Albright, J., Garrett, J. M., & Curtis, K. M. (2007). Pregnancy and STD prevention 
counseling using an adaptation of motivational interviewing: a randomized controlled 
trial. Perspect Sex Reprod Health, 39(1), 21-28.  
Pringle, J. L., Boyer, A., Conklin, M. H., McCullough, J. W., & Aldridge, A. (2014). The 
Pennsylvania Project: pharmacist intervention improved medication adherence and 
reduced health care costs. Health Affairs, 33(8), 1444-1452.  
70 
Rau, J., Ehlebracht-König, I., & Petermann, F. (2008). Impact of a motivational intervention on 
coping with chronic pain: results of a controlled efficacy study. Schmerz (Berlin, 
Germany), 22(5), 575-578, 580-575.  
Roebuck, M. C., Liberman, J. N., Gemmill-Toyama, M., & Brennan, T. A. (2011). Medication 
adherence leads to lower health care use and costs despite increased drug spending. 
Health Affairs, 30(1), 91-99.  
Rollnick, S., Miller, W. R., & Butler, C. (2008). Motivational Interviewing in Health Care: 
Helping Patients Change Behavior: Guilford Press. 
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the 
pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99(16), 
2192-2217.  
Sauter, S., Murphy, L., Colligan, M., Swanson, N., Joseph Hurrell, J., Frederick Scharf, J., . . . 
Tisdale, J. Stress at Work: U.S. Department of Health and Human Services, Public Health 
Service, Centers for Disease Control and Prevention, National Institute for Occupational 
Safety and Health. 
Schaubroeck, J., & Merritt, D. E. (1997). Divergent effects of job control on coping with work 
stressors: The key role of self-efficacy. Academy of Management Journal, 40(3), 738-
754.  
Schnall, P. L., Landsbergis, P. A., & Baker, D. (1994). Job strain and cardiovascular disease. 
Annual review of public health, 15(1), 381-411.  
Schnall, P. L., Pieper, C., Schwartz, J. E., Karasek, R. A., Schlussel, Y., Devereux, R. B., . . . 
Pickering, T. G. (1990). The relationship between'job strain,'workplace diastolic blood 
pressure, and left ventricular mass index: results of a case-control study. Jama, 263(14), 
1929-1935.  
Schneiderman, N., Ironson, G., & Siegel, S. D. (2005). Stress and health: psychological, 
behavioral, and biological determinants. Annual Review of Clinical Psychology, 1, 607.  
Schram, M. T., Baan, C. A., & Pouwer, F. (2009). Depression and quality of life in patients with 
diabetes: a systematic review from the European depression in diabetes (EDID) research 
consortium. Current diabetes reviews, 5(2), 112.  
Schulz, P., Kirschbaum, C., Prüßner, J., & Hellhammer, D. (1998). Increased free cortisol 
secretion after awakening in chronically stressed individuals due to work overload. Stress 
and Health, 14(2), 91-97.  
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication 
adherence on hospitalization risk and healthcare cost. Medical care, 43(6), 521-530.  
Stansfeld, S., & Candy, B. (2006). Psychosocial work environment and mental health—a meta-
analytic review. Scandinavian journal of work, environment & health, 443-462.  
Steenland, K., Fine, L., Belkić, K., Landsbergis, P., Schnall, P., Baker, D., . . . Karasek, R. 
(2000). Research findings linking workplace factors to CVD outcomes. Occupational 
medicine (Philadelphia, Pa.), 15(1), 7.  
Strecher, V. J., DeVellis, B. M., Becker, M. H., & Rosenstock, I. M. (1986). The role of self-
efficacy in achieving health behavior change. Health Education & Behavior, 13(1), 73-
92.  
Theorell, T., & Karasek, R. A. (1996). Current issues relating to psychosocial job strain and 
cardiovascular disease research. Journal of occupational health psychology, 1(1), 9. 
71
Theorell, T., Perski, A., Åkerstedt, T., Sigala, F., Ahlberg-Hultén, G., Svensson, J., & Eneroth, P. 
(1988). Changes in job strain in relation to changes in physiological state: a longitudinal 
study. Scandinavian journal of work, environment & health, 189-196.  
Törnroos, M., Elovainio, M., Keltikangas-Järvinen, L., Hintsa, T., Pulkki-Råback, L., Hakulinen, 
C., . . . Raitakari, O. T. (2015). Is There a Two-Way Relationship Between Cynicism and 
Job Strain? Evidence From a Prospective Population-Based Study. Journal of 
Occupational and Environmental Medicine, 57(5), 479-484.  
Vermeulen, M., & Mustard, C. (2000). Gender differences in job strain, social support at work, 
and psychological distress. Journal of occupational health psychology, 5(4), 428.  
Vrijkotte, T. G., Van Doornen, L. J., & De Geus, E. J. (2000). Effects of work stress on 
ambulatory blood pressure, heart rate, and heart rate variability. Hypertension, 35(4), 
880-886.  
